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Barrett’s Oesophagus (BO) is an acquired condition which alters the normal structure 
of the distal oesophagus.  BO is important as it is the only known precursor lesion for 
Oesophageal Adenocarcinoma (OAC) with an annual conversion rate of 
approximately 0.3%.  There is a strong correlation between acid-reflux and the 
development of BO, with patients with BO having a high incidence of bile acids in 
their refluxate, bile acids have been implicated in ER stress and disruption of protein 
folding which may be important in the transition from BO to OAC. 
Over-expression GPx7 has been shown to protect oesophageal cells from bile acid 
induced stress.  However, there is evidence to suggest that GPx7 is down regulated 
by hypermethylation of its promoter in BO.  Prdx4 also has an antioxidant role but 
has not been investigated fully in BO and OAC,  Finally AGR2 is a member of the 
PDI family which has been implicated in a number of cancers and may play a role in 
the development of OAC.   
This thesis did not find any noticeable expression of GPx7 in OE cells or in tissue 
samples of BO and OAC.  Western blotting of OE cells showed a difference in redox 
poise between OE19 and OE33 cells and IHC showed expression of Prdx4 is 
gastric-like cells in BO but none in OAC tumour cells.  AGR2 did not appear to be 
expressed in the normal oesophagus but was present in gastric-like secretory cells in 
BO which appeared to remain closely associated with tumour cells in OAC.  Cellular 
experiments showed that AGR2 forms redox dependant interactions within OE cells.  
Taken together this may suggest a relationship between Prdx4 and AGR2 and the 
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1.1 The Structure and Histology of the Oesophagus 
The oesophagus is a muscular tube which begins at the pharynx and ends at 
entrance to the stomach comprising, from the outside in, of two muscle layers, 
longitudinal and circular, a submucosal layer,  the muscularis mucosa layer, the 
lamina propria and finally the epithelial layer.  The epithelium of the oesophagus 
consists of a stratified layer of squamous epithelial cells, containing small ducts 
linked to lubricant secreting, submucosal glands and  changes to a non-stratified 
columnar epithelium at the gastro-oesophageal junction (Keshav, 2004).   
Viewed histologically, the epithelial cells, at the luminal edge of the oesophageal 
epithelium, appear flattened, becoming gradually larger as the cells transition 
towards the basal zone, many of these cells are rich in glycogen. The basal zone of 
the oesophageal epithelium  comprises of a variable number of layers of rectangular 
or cuboidal cells which lack glycogen and is scattered with melanocytes and 
neuroendocrine cells.  Below the oesophageal epithelium is the lamina propria.  The 
interface, between the basal epithelial layer and the lamina propria is irregular and 
tongues of the lamina propria extending towards the luminal surface.   The lamina 
propria consists of a glycoaminoglycan matrix in which fibroblasts and loosely 
arranged collagen fibres are embedded, along with lymphocytes, eosinophils and 
occasionally plasma cells and mast cells.  The muscularis mucosae, below the 
lamina propria, is variable in thickness, being thicker towards at the oespohageal-
gastric junction.  The muscle fibres of the muscularis mucosae, appear to be 
arranged irregularly in the upper portions of the oesophagus transitioning to 
continuous sheets of longitudinal and circular smooth muscle in the lower third 
(Stevens & Lowe, 1997).  
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1.2 Barrett's Oesophagus 
Barrett’s Oesophagus (BO) is an acquired condition which alters the normal structure 
of the distal oesophagus.  In BO the stratified squamous epithelium of the 
oesophagus, near the oesophageal gastric junction, is replaced by a metaplastic 
columnar epithelium which can comprise three different morphologies.  These are; 
atrophic gastric-fundic type epithelium containing parietal and chief cells; transitional 
epithelium with cardic-mucus secreting glands and specialized columnar epithelium 
with intestinal-like goblet cells.  However, there is some disagreement in clinical 
practice as to what constitutes BO.  American gastroenterologists require the 
presence of specialised columnar epithelium for a positive diagnosis of BO, whereas 
British guidelines consider the possibility of diagnosing BO on the presence of 
gastric metaplasia only (di Pietro, et al., 2014).   
BO, in itself is relatively benign and could  be considered as an adaptive mutation in 
response to refluxing gastric contents, containing acid and bile. Ostrowski et al, 
utilising  a genomic and proteomic approach discovered that there were over 2822 
genes differentially expressed between 23 paired samples of Oesophageal 
squamous epithelium and BO samples including heat shock proteins and those that 
reflected defence, such as MUC1 and MUC5AC and repair, such as TFF2. 
(Ostowski, et al., 2007). Clinically, BO is important as it is the only known precursor 
lesion for Oesophageal Adenocarcinoma (OAC) (di Pietro, et al., 2014); (Watson & 
Galloway, 2014).   
Oesophageal cancer is the 7th most common cancer in men, the14th most common 
in women (di Pietro, et al., 2014) and has shown an approximate 8-fold increase in 
incidence over the last three decades (Watson & Galloway, 2014).  Oesophageal 
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cancer is aggressive in nature and is relatively asymptomatic in its early stages 
which results in a late diagnosis, resulting in Oesophageal cancer being the 4th and 
7th highest cause of cancer related deaths in men and women respectively with a 
5year survival rate of 5-10% (di Pietro, et al., 2014) (Watson & Galloway, 2014).  
Suffers of BO have a 0.3% annual conversion rate to OAC however there has been 
an increase in the incidence of BO and a decrease in age of presentation.  According 
to the United Kingdom Barrett’s Oesophagus Registry (Watson, 2014) 27% of the 
12,000 registered BO suffers were diagnosed before the age of 55 (Watson & 
Galloway, 2014).   
The development of BO into OAC is thought to be a multi-step process where the 
metaplastic, BO epithelium is thought to sequentially transition through a low grade 
dysplastic epithelium, to a high grade dysplastic epithelium and finally into invasive 
OAC (To, et al., 2016).  The underlying mechanisms which drive the transition are 
unclear.  One possible theory proposed is transdifferentiation, a change of one cell 
type into another.  The early developing Oesophagus is composed of simple 
columnar cells which differentiate into the normal squamous epithelium during 
development.  As the oesophagus develops the appearance of squamous epithelial 
cells coincides with the down regulation of Hh signalling, which transmits the 
information required by embryonic cells for proper differentiation.  Wang D et al 
proposed that Oesophageal injury from acid and bile reflux could cause aberrant re-
activation of the Hh signalling pathway and this could be the cause of the 
transdifferentiation to columnar cells in BO.  Wang  et al showed that over 
expression of Sonic Hedgehog in mouse Oesophagus epithelium induces columnar 
gene expression, In addition Wang et al found 70 cases of BO with activated Hh 
signalling and so proposed that aberrant re-activation of the Hh signalling pathway 
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could be the cause of the transdifferentiation to columnar cells in BO (Wang, et al., 
2010).  
While transdifferentiation explains the observed replacement of the normal 
squamous epithelium with columnar epithelia, which is seen in BO, it fails to explain 
the rise in other cell lineages seen in BO.  Given that the cell types observed in BO 
resemble those represented in intestinal tissue it is possible that oesophageal stem 
cells undergo transcommitment into an intestinal type stem cells. The exact location 
of the stem cell which gives rise to BO is unknown although a number of candidates 
exist, namely squamous oesophageal stem cells in the basal epithelial layer, stem 
cells present in the submucosal glands (Burke & Tosh, 2012) and finally gastric stem 
cells which have migrated from the gastric cardia at the gastro-oesophageal junction 
(Quante, et al., 2012) 
 There is also evidence to suggest other possibilities.  Wang  et al showed that a 
discrete population of embryonic epithelial cells persist in adult mice and human at 
the squamous-columnar junction and can migrate to the site of squamous epithelial 
injury and populate (Wang, et al., 2011). Additionally, a rat model of Reflux 
Oesophagitis (RO) showed evidence that multi-potential stem cells migrated from 
bone marrow via the blood to the site of the reflux damaged epithelium (Saosi, et al., 
2008).   
Whilst  environmental and lifestyle factors, appear to be a major correlative factor in 
the development of BO (Table 1.1) there appears to be some evidence of  a possible 
genetic relationship in the development of BO and OAC.  Studies have shown that 
within different populations of BO and OAC  approximately 7% of sufferers show 








Chronic Heartburn, Erosive Oesophagitis or 
Symptoms of Gastro-Oesophageal reflux 
and higher in patients with an onset of reflux 
<30 years of age 
 
Strong association; particularly with 
longer BO segments 
Obesity particularly in people with a high 
ratio of Abdominal fat compared to 
subcutaneous  
 
Strong association, increasing with 
BMI and waist circumference 
Smoking status  Some association.  Differing studies 
conflict on the association with 
smoking and BO.    
 
Strong association in OAC with a 
dose-response relationship.  Still 
elevated in ex-smokers but 
decreasing with cessation period 
 
Gender, Race and Age Higher male to female association 
and more prevalent in Caucasians, 
risk increases with age   
 
Diet Increased risk associated with low 
vegetable consumption and high 
consumption of red and processed 
meats. 
 
Genetic Factors An increased risk has been 
associated with a familial history of 
BO and or OAC  
 
Pregnancy Complications There is some association with the 
development of BO and low birth 
weight but not with the development 
of OAC.  Conversely premature birth 
is associated with an increased risk 
of OAC but not BO.   
 
Table 1.1:  Risk Factors for the development of Barrett’s Oesophagus (di Pietro, et al., 2014) 




A number of genome wide association studies have identified  loci that correlate with 
increased disease risk, the most notable of which are described below.   
The Esophageal Adenocarcinoma Genetics Consortium tested over 521,000 single 
nucleotide polymorphisms (SNPs) and discovered an association with a SNP on 
chromosome 6p21 within the major histocompatibility complex, odds ratio (OR) (95% 
confidence Interval (CI)) of 1.21 and a SNP on chromosome 16q24 OR (95%CI) of 
1.14, which codes for FOXF1, a protein thought to be associated with Oesophageal 
development (The Esophageal Adenocarcinoma Genetics Consortium and the 
Wellcome Trust Case Control Consortium , 2012). Another group headed by David 
Levine found three possible SNPs, 19p13 (CRTC1) associated with oncogenic 
activity when aberrantly activated, 9q22 in BARX1 a transcription factor related to 
oesophageal specification and FOXP1 on 3p14 a regulator of oesophageal 
development (Levine, et al., 2013). Whatever the driver of the change in BO there 
appears to be evidence of a progressive increase in mutational load with a 
subsequent accumulation of general genomic instability and  oncogenic events  such 
as  the loss of the tumour suppressor genes  CDKN2A and TP53 (Ross-Innes, et al., 
2015) (Stachler, et al., 2015).   
Although there is evidence of a genetic subset of people who are at an increased 
risk of the transition of BO to OAC, one of the main risk factors for BO appears to be 
the presence of acid reflux  (Table1.1).   Gastro-Oesophageal Reflux Disease 
(GORD) and erosive Oesophagitis are strongly correlated with the development of 
BO.  Fass et al found that 12% of those presenting with GORD and 36% of those 
with Oesophagitis had BO.  Additionally they demonstrated that the length of BO 
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segments correlated with the exposure to acid in the Oesophagus.  They found that 
patients with shorter segments of BO experienced significantly less exposure to 
reflux acid than those  with longer segments of BO both when upright or supine, 
concluding that duration of acid exposure is an important factor in determining the 
length of the Barrett's mucosa  (Fass, et al., 2001). There appears to be a strongly 
correlated link between increased acid reflux and BO and patients with BO have a 
high incidence of bile acids in their refluxate (Fujimura, et al., 2011) implicating bile 
acids as etiologic agents in cancers of the gastrointestinal tract (Bernstein, et al., 
2009). Dvorak et al demonstrated that a bile acid cocktail, comprising of the sodium 
salts of   glycocholic acid, taurocholic acid, glycodeoxycholic acid, 
glycochenodeoxycholic acid and deoxycholic acid, acidified to pH4 could induce 
oxidative stress in Human Barrett’s Oesophagus tissue.  In addition they showed that 
the combination of bile acids and low pH caused an increase in oxidative stress and 
oxidative DNA damage, shown by an increase in 8-hydroxy-deoxyguanosine, a 
marker for oxidative DNA damage in BO, Seg-1 and HET-1A cells (Dvorak, et al., 
2007). The bile salt deoxycholic acid has also been implicated as a carcinogen in 
gastrointestinal cancer by indirectly damaging DNA through the production of 
reactive oxygen and reactive nitrogen species (ROS/RNS) (Bernstein, et al., 2005) 
and with oxidative and Endoplasmic Reticulum (ER) associated stress, protein 
misfolding and calcium ion (Ca2+) imbalances  in human cholestatic  liver disease 
(Bernstein, et al., 1999).  These associations suggests that acid reflux and its effects 





1.3 The Endoplasmic Reticulum 
The Endoplasmic reticulum (ER) is a continuous membrane system, interconnected 
with the nuclear envelope (Figure 1.1).  It is comprised of a single membrane bilayer,  
forming a single continuous lumen which has various domains that perform different 
functions, including protein synthesis, folding, transport to the Golgi and lipid 
biogenesis. (Schwarz & Blower, 2016).  The ER is continuous with the nuclear 
envelope (NE) and consists of two main domains,  the rough endoplasmic reticulum 
(RER) and the smooth endoplasmic reticulum (SER).  The  NE surrounds the 
nucleus, it consists of an inner nuclear membrane (INM) and an outer nuclear 
membrane (OMN).  These are large cisternal membranes separated by the inter 
nuclear membrane space (English & Voeltz, 2013).  The NE acts as a barrier to 
selectively control the entry and exit of molecules to the nucleus.  Transport of 
molecules between the nuclear and cytoplasmic compartments is facilitated by 
nuclear pore complexes that bridge the IMN and OMN (Schwarz & Blower, 2016).  
The ER branches out from the ONM as an interconnected network of cisternae 
comprising the RER and the SER (Figure 1.1) with the conformationally stacked, flat 
cisternae of the RER localised nearest the NE (Schwarz & Blower, 2016) (English & 
Voeltz, 2013).  The RER comprises of two lipid bilayers with an intervening lumen 
which varies in size.  The luminal space is consistently around 50 nm in mammals 
and 30 nm in yeast (Schwarz & Blower, 2016) and the sheets of the RER are 
connected by helicoidal membrane motifs (Tesrasaki, et al., 2013).  The RER is 
defined by the high density of ribosomes on its cytosolic surfaces and its function is 
the synthesis, folding and modification of proteins destined to be secreted or 









Figure 2.1 The Endoplasmic Reticulum:  A graphical representation of the ER.   The ER 
abuts the Nucleus and is comprised of two defined types the rough ER and  the smooth ER.  
As the ER is the site of protein folding, Ribosomes, synthesising nascent proteins are 




The SER comprises a highly curved and smooth network of interconnected tubules 
and is defined by the lower density of ribosomes (English & Voeltz, 2013).  The SER 
is highly dynamic and constantly rearranging and is considered to be the primary site 
of Lipid biogenesis  (Schwarz & Blower, 2016).   
1.4 Protein entry into the Endoplasmic Reticulum  
A newly synthesised, nascent protein chain exists in a conformation determined by 
its amino acid sequence.  Many nascent proteins, in order to assume a form that is 
biochemically active, must undergo some form of protein folding and this process 
must be reproducible in order that every protein translated from a particular mRNA 
sequence results in a form fit for purpose.   
Proteins that are expressed at the cell surface, are part of the secretory pathway or 
are destined to be secreted are targeted to the ER by a signalling sequence which is 
located at the N-terminus of the emerging nascent polypeptide chain (Figure 1.2).  
This signal sequence is usually around 25 amino acids in length and comprises of 8-
12 hydrophobic amino acids preferentially formed in an α-helix the exact composition 
of which is variable in length, shape and amino acid composition (Heijne, 1985).  
This signal sequence binds to a Signal Recognition Particle (SRP), which facilitates 
the targeting of the translating protein to the ER membrane (Figure 1.2A) (Pool, 
2005).  The SRP is a ribonucleoprotein complex comprising of, in mammals, a 7SL 
RNA of approximately 300 nucleotides, formed into a  double stranded secondary 
structure in complex with six protein subunits (SRP 9, 14,19, 54, 68 and 72) and can 
be thought of as consisting of two structural domains, named the Alu and the S-
domain (Walter & Blobel, 1983).  The Alu-domain is made up from helices 3-5 of the 










Figure 1.2 Co-Translocation of Nascent Proteins into the Endoplasmic Reticulum.   The Nascent protein chain ER 
targeting  sequence emerges from the Ribosome Nascent Chain Complex (RNC). arresting Translation.  The Signal 
Recognition Particle (SRP) associates with the ER localisation sequence.  This targets the nascent protein to the ER by 
binding to the SRP-receptor (SR) on the surface of the ER (A), the SR consists of an α and β subunit, binding to the SR 
reinitiates Translation.  The RNC docks to  the Sec61 complex and the Nascent Protein Chain begins translocation into 
the ER (B) .  The nascent protein chain passes through the Sec61 complex as a loop (C), the ER targeting sequence is 
sniped by Signal sequence peptidase complex (Spase) .   BiP binds to the nascent chain, in an ATP dependant manne r 
(D) and the nascent chain is released from the RNC and is chaperoned to folding in the ER (E).  [reviewed in 
(Zimmermann, et al., 2011)]  
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The S-domain comprises of the rest of the 7SL RNA and the SRP19, the SRP54, the 
SRP68 and  the SRP72 protein subunits.  Of all the subunits SRP54 is key to the 
function of the SRP, in that it is involved in interaction with the ribosome, signal 
sequence recognition and interaction between the SRP and the ER membrane SRP-
receptor (SR) (Nyathi, et al., 2013).   Structurally SRP54 is comprised of 3 main 
domains an α-helical, methionine rich domain (M) located at the C-terminus; a 
GTPase domain (G) and a N-terminal helical domain (N).  The M domain binds the 
nascent chain signal sequence and the N and G domains are involved  with in the  
interaction with the SR.  The M and NG domains are joined by a highly conserved 
and flexible linker which permits the subunit to undergo structural rearrangement and 
allows communication between the domains (Nyathi, et al., 2013) (Hainzl, et al., 
2011).   
Unique to the eukaryotic SRP, binding of the signal sequence to the SRP14 subunit 
of the SRPs ALU domain, is capable of causing a transient arrest in the elongation of 
the nascent chain.  Experiments with SRP mutants compromised in their ability to 
arrest elongation have demonstrated defects in translocation, suggesting that the 
arrest capability of the SRP could be to ensure that the nascent chain remains 
competent unti l the RNC has bound to the translocon  (Nyathi, et al., 2013).  
The SRP binds to the Ribosome Nascent Chain Complex (RNC) with low affinity.   
However, it is only the presence of an exposed signal sequence that leads to high 
affinity binding through the M domain of the SRP subunit of the SRP (Nyathi, et al., 
2013).  Binding of the signal sequence causes a conformational change in SRP54 
which is thought to promote receptor engagement (Hainzl, et al., 2011).   
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Once formed the RNC-SRP complex is targeted to the ER membrane bound SR.  
The SR (Figure 1.2A) comprises of two subunits, namely SRα and SRβ.  SRβ is a 
30kDa integral membrane protein anchored to the ER membrane via a single 
transmembrane domain.  SRα is a 70 kDa protein that is tightly bound to SRβ at its 
N-terminal SRX domain, Its C-terminus region includes a GTPase domain and has a 
high homology with the NG domain of SRP54 (Nyathi, et al., 2013).  SRα also has a 
GTPase domain that only interacts with SRβs SRX domain when it is in a GTP 
bound state, Schwartz and Blobel suggest that the GTP cycle of SRβ may control 
the association and disassociation of the SR (Schwartz & Blobel, 2003).  The SRα 
subunit of the SR forms the interaction between the SR and the SRP. The NG 
domain of SRP54 forms a pseudo homodimer with the SRX domain only when the  
GTPase domains of both SRP54 and SRX have bound GTP (Nyathi, et al., 2013).  
There is also some evidence to suggest that kinetics of the formation of the SRP-SR 
complex provides some proof reading ability, in that only the binding of genuine ER 
targeting sequences to the SRP promote rapid and stable SRP-SR dimerisation 
(Zhang, et al., 2010).   
 
Protein entry into the ER is facilitated by the Sec61 translocon complex (Figure 
1.2B).  The Sec61 complex is a heterotrimer of two highly conserved subunits α and 
γ and a less well conserved β subunit.  The α subunit, which forms the pore that 
surrounds the translocating nascent chain during transfer across the ER membrane 
(Ng & Walter, 1994), has ten transmembrane (TM) domains and can be thought of 
as being in two distinct halves, TM 1-5 and  TM 6-10.  The TMs are arranged to form 
a central pore, with a cytosolic loop between TMs 5 and 6, which functions as a 
hinge allowing the opening of the pore. The luminal side is occluded by a plug 
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formed by a sub domain of the 2nd transmembrane domain.  The γ subunit traverses 
the ER membrane diagonally across the back of the α subunit and has a role in 
opening the luminal side of the pore complex to allow protein entry in the ER lumen.  
The β subunit barely contacts the α subunit and its exact function has not been fully 
elucidated (Nyathi, et al., 2013).   
Binding of the RNC to the Sec61complex (Figure 1.2) initiates opening of the pore 
complex and passage of the nascent protein chain into the ER lumen.  Evidence 
suggests that the nascent chain signal sequence binds at the cytosolic side of the 
translocon and forms a hairpin-loop until the nascent protein is released from the 
RNC.  The signal sequence can then be cleaved by signal peptide peptidases 
Spase, (Figure 1.2C) (Shaw, et al., 1988). However there is also evidence that 
suggests that initially the signal sequence may be inserted head first into the pore, in 
this case at some point the signal sequence flips, inside the pore, into a hairpin-loop 
leading to the translocation of the c-terminal residues of the nascent chain and may 
require the interaction of accessory proteins Sec63b and ERj1 (Nyathi, et al., 2013) 
(Devaraneni, et al., 2011). As translocation draws to completion, the nascent protein 
chain is chaperoned by the ER chaperone grp78 (BiP, Figure 1.2D) and post 
translationally modified, folded and stabilised by the addition of intramolecular 
disulphide bonds between chains of a single protein or intermolecular disulphide 
bonds between separate chains.      
 
1.5 Oxidative Protein Folding in the ER 
  Disulphide bond formation is necessary to confer stability for secreted proteins, 
when they are exposed to the extracellular environment or, in the case of recycled 
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membrane proteins, passage through acidic endocytic compartments (Bulleid, 2012).   
The formation of disulphides begins as a nascent protein chain is translocated in to 
the ER.  The initial collapse of a nascent chain into its secondary structure brings 
cysteine residues close enough together for the formation of disulphide bonds.  The 
lumen of the ER is a more oxidised environment than the cytosol and as such 
favours the oxidation of free thiol groups (-SH) and the  formation of disulphide 
bonds (S-S).  However, correct disulphide bond formation requires enzymatic help to 
promote bond formation between cysteine residues and to remove those disulphide 
bonds that may form during folding but are not required by the protein's final form 
(Bulleid, 2012) (Braakman & Bulleid, 2011).  Central to this cycle of oxidation and 
reduction is the protein disulphide isomerase (PDI) family of enzymes (Bulleid, 
2012).   
The PDI family of enzymes have the ability to serve as molecular chaperones and to 
act as oxireductases and as isomerases, forming, breaking and rearranging 
disulphide bonds within their protein 'clients' (Figure 1.3A) (Benham, 2012 ).  
Formation of disulphide bonds requires that PDI family members be oxidised, there 
are a number of specific oxidases that, while being unable to introduce disulphide 
bonds themselves  into client proteins, can specifically oxidise PDI family members 
(Bulleid, 2012), with the exception of quiescin sulfydryl oxidase (QSOX), a Golgi 
localised protein, which has been shown to be able to introduce disulphide bonds 
without the aid of additional partners.  However, being localised to the Golgi 
apparatus it is thought not to be involved in oxidative protein folding (Chakravarthi, et 




   
Figure 1.3  PDI  A) Graphical representation of PDIs action on client proteins (not to scale).   
PDI  can act as  a catalyst with the ability to oxidise, reduce or isomerise disulphide bonds.  
B)  PDI contains two catalytic  a domains (a, a') and two non-catalytic b domains (b, b') The  
a' and  b' domains are connected  by an X-linker region.  The  C-terminal KDEL mediates ER 
retention/retrieval  (adapted from (Benham, 2012 )) 
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Structurally, the main building block of PDI is the thioredoxin domain.  PDI contains 
two active thioredoxin domains  a and a' as well as two inactive b and b' (Figure 
1.3B).  The b' and a' domains are separated by an x-linker region which contains a 
hydrophobic cap that can regulate ligand binding and homodimerisation (Benham, 
2012 ). The active sites of a PDI family member usually contain a CxxC motif, which 
is normally CGHC in PDI (Benham, 2012 ). The intramolecular disulphide bond in the 
CxxC motif has a high reduction potential compared to that of unfolded client 
proteins allowing the ready donation of its disulphide bond to a protein with a 
reduced thiol (Benham, 2012 ).   
The mechanism of oxidative protein folding can be considered as a series of 
oxidation reactions between PDI family members and different oxidases. The main 
oxidase is ER Oxidoreductase 1 (ERO1) but both Glutathione Peroxidase 7/8 
(GPx7/8) and Perioxiredoxin IV(Prdx4) have also been suggested as capable of 
oxidising PDI (Figure 1.4) (Bulleid, 2012).     ERO1 and PDI form the main pathway 
for disulphide bond formation in the ER,   ERO1 is a glycosylated flavoprotein 
associated with the luminal side of the ER membrane.  It has two homologues,  in 
homo sapiens, ERO1α and ERO1β (Sevier & Kaiser, 2008). These homologues 
appear to undertake similar functions but have different tissue distribution (Pagani, et 
al., 2000). ERO 1 has two catalytic sites each featuring a pair of cysteines. The 
'active' site is located close to the bound FAD cofactor and the 'shuttle' site is located 
on a flexible loop.  ERO1 promotes disulphide bond formation by utilising the 
oxidiation potential of molecular oxygen and its bound FAD cofactor to generate 
internal disulphide bonds that it can transfer to the client protein via PDI.  This is 
achieved by a series of thiol-disulphide bond exchange reactions (Figure 1.4A).  
Catalysis by ERO1 involves the direct oxidation of PDI by the shuttle site and the re-
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oxidation of the reduced shuttle site by internal thiol-disuphide exchange between 
the shuttle and the active sites. Molecular oxygen and FAD in turn re-oxidise the 
active site producing H2O2.  (Bulleid, 2012) (Sevier & Kaiser, 2008).   
ERO1 is not the only ER resident protein that is capable of oxidase activity and has 
been found to interact with PDI. Both Nguyen et al and Wang et al have 
demonstrated that GPx7 and GPx8 have the ability, in the presence of H2O2, to  
oxidise PDI and facilitate disulphide bond formation in client proteins (Nguyen, et al., 
2011) (Wang, et al., 2014).  GPx7 and 8 are members of the GPx family,GPx7 is a 
soluble ER protein and GPx8 is a type 1 membrane protein (Bulleid, 2012).   Nguyen 
et al demonstrated evidence that both GPx7 and GPx8 were ER localised 
glutathione peroxidases closely associated with ERO1 and neither demonstrated 
substantial glutathione peroxidase activity, instead they demonstrate PDI peroxidase 
activity ie they show a preference for accepting electrons from PDI.  In vitro studies 
demonstrated that addition of GPx7/8, PDI and peroxide to a reduced unfolded 
protein resulted in disulphide formation and rapid refolding into its native state. They 
also demonstrated that addition of GPx7/8 to a mix of PDI, ERO1α and reduced 
glutathione (GSH) resulted in a significant increase in oxygen consumption.  
Together this information provides evidence to suggest that GPx7 and Gpx8 form 
part of a pathway designed to efficiently utilise the peroxide produced by the main 
ERO1-PDI pathway for disulphide bond formation (Nguyen, et al., 2011).   





Figure 1.4 Mechanisms of the interactions between the oxidases ERO1, GPx7/8 and Prdx4.  A) Thiol groups within ERO1 form a disulphide bond donating electrons to 
FAD which is reduced to FADH2.,PDI accepts electrons from ERO1, resulting in the oxidation of PDI and the reduction of the disulphide bond in ERO1 which it can then pass on 
to its client protein.  Molecular oxygen acts as the ultimate electron acceptor regenerating FAD and producing H2O2.  B) GPx7/8 utilises H2O2. resulting in the sulphenylation of 
the active cysteine which is reduced passing its sulphide to PDI, oxidising PDI and forming a disulphide bond that can be donated to a client protein.  Finally, C) The thiol groups 
within Prdx4 can be considered resolving and peroxidatic, in a similar way to GPx7/8 the first step is the utilisation of H2O2.  for the sulphenylation of the peroxidatic cysteine 
within Prdx4, this quickly interacts with a resolving cysteine forming a disulphide bond which is passed to PDI and ultimately from PDI to a client protein.  (Bulleid, 2012) 




This evidence is further supported by Wang et al, who showed that GPx7 could 
utilise the peroxide generated by ERO1α to accelerate disulphide dependent protein 
folding both in vitro and in vivo.  The mechanism by which, they suggest, GPx7 
utilises H2O2 to oxidise PDI is shown in Figure 1.4B.  As can be seen H2O2 oxidises 
a GPx7 cysteine, Cys57 to sulphenic acid.  This can then either form an intra 
molecular disulphide bond with Cys86 or interact with PDI directly.  They further 
suggest that ERO1, PDI and GPx7 form a triad which can utilise a single molecule of 
oxygen to produce two disulphide bonds and two molecules of H2O (Wang, et al., 
2014)  
In addition to the evidence showing that GPx7 and 8 are capable of directly oxidising 
PDI to drive disulphide bond formation, evidence has also been presented to show 
that Prdx4 has the capacity to directly oxidise PDI and drive disulphide bond 
formation in the presence of H2O2 (Tavender, et al., 2010).  Prdx4 is a member of the 
peroxiredoxin family, Prdx4 contains an N terminal signal sequence which was 
thought to allow secretion but Tavender et at demonstrated that it was actually 
localised to the ER .Prdx4 is considered a member of the typical 2-Cysteine (2-Cys) 
family of peroxiredoxins, in that in addition to its redox-active 'peroxidatic' cysteine it 
also contains an additional cysteine, known as the resolving cysteine near its C-
terminus.  Catalytic activity of these 2-Cys peroxiredoxins is facilitated by the 
formation of toroid-shaped decamers constructed of  5 catalytic dimers.  Multimer 
formation provides the optimal arrangement of the peroxidatic cysteines to maximise 
catalysis. (Tavender, et al., 2008) (Wang, et al., 2012).  Prdx4 reacts as a scavenger 
of H2O2 in the ER (Wang, et al., 2012), where reaction with H2O2 causes the 
peroxidatic cysteine to become sulphenylated (Figure 1.4).  Sulphenylation causes a 




one chain in the dimer close to the sulphenylated peroxidatic cysteine on the other 
(Bulleid, 2012), destabilising the Prdx4 decamer complex in the process (Tavender, 
et al., 2008) and forming a disulphide bond (Figure 1.4).  The formation of this 
disulphide allows the Prdx4 dimer to readily accept electrons from reduced PDI, 
oxidising the PDI active site to form a disulphide that can then be passed to a client 
protein (Tavender, et al., 2010) (Bulleid, 2012) removing ERO1 generated H2O2 and 
forming two disulphide bonds and water for the cost of a single reduced molecule of 
oxygen.   
 
1.6 Disruption to Oxidative Protein Folding may result in ER stress and could 
contribute to the pathogenesis of Barrett's Oesophagus and Oesophageal 
Adenocarcinoma.   
There exists a link between cellular damage or injury,  oxidative stress and  ER 
stress and perturbation of oxidative protein folding in the ER (Zhang, 2010) (Burton & 
Jauniaux, 2011).  Bernstein et al demonstrated that exposure of HepG2 cells to the 
bile salt deoxycholate, induced the increased activation of promoters and 
transcription factors associated with the response to DNA damage (Gadd153, hsp70 
and c-fos), oxidative stress (NF-κβ, Gadd153, hsp70 and c-fos) and those that 
respond to protein misfolding (grp78 and hsp70) and ER stress (grp78) (Bernstein, et 
al., 1999). The activation of grp78 in response to oxidative stress in a liver cancer 
cell line is a good indicator of the link between cellular stresses and ER stress, as 
grp78 is one of the main chaperones in the ER and increased expression is an 
indication of the activation of the ER unfolded protein response (UPR) which 




expression of components of the oxidative protein machinery (Schroder & Kaufman, 
2005). Over-expression of grp78 is not restricted to cancers of the liver, Langer et al 
found that grp78 mRNA, which correlated with actual protein expression, was highly 
expressed in primary resected oesophageal adenocarcinoma tissue sections, 
particularly in early stage OAC (Langer, et al., 2008).  There is also evidence that 
suggests that activation of Gadd153, by DNA damage and oxidative stress, 
sensitises cells to ER stress leading to a depletion of cellular glutathione (GSH) and 
increased production of ROS  (McCullough, et al., 2001).  Glutathione has an 
important role in oxidative protein folding, assisting PDI, in the reduction of the 
disulphide bonds of misfolded proteins (Chakravarthi, et al., 2006). This evidence, 
taken together, suggest that cellular injury, such as from the acid exposure of 
GORD, a known precursor of BO, results in the accumulation of misfolded proteins in 
the ER, depleting cellular GSH and so leading to an increase in oxidative protein 
folding to compensate. 
 Western Blotting of lysates of the adenocarcinoma cell line OE33 compared to the 
squamous cell carcinoma cell line OE21 showed a greater sensitivity to stress, 
induced by deferoxamine mesylate (DFOM), CoCl2 and Tunicamycin, determined by 
an increase in ERO1α expression in the OE33 cell line compared to OE21 cells 
(Battle, et al., 2013). A natural consequence of the increase in expression of ERO1α 
would , therefore, be an increase in the generation of H2O2 (Figure 1.4A) as a by 
product. However, as can be seen in Figure 1.4 B and C both GPx7/8 and Prdx4, 
resident in the ER can utilise H2O2 to both remove ERO generated H2O2 and to 
increase protein folding.  Ramming et al showed that loss of GPx8 resulted ER 
stress, leakage of H2O2 into the cytosol and cell death. They suggest that the ER 




prevention of H2O2 accumulation and leakage from the ER and that Prdx4 only 
assists in H2O2 detoxification when levels of ERO catalysed H2O2 is maximised 
(Ramming, et al., 2015).  Further Peng et al demonstrated that GPx7 has the 
capacity to prevent oxidative DNA damage.  They showed that GPx7 expressing 
cells had lower levels of H2O2, intracellular ROS and oxidative DNA damage, in 
particular double strand breaks compared to controls when exposed to an acidified 
bile acid cocktail (Peng, et al., 2012).    That the protective ability of GPx7 and Prdx4 
does not seem to occur suggests that either the production of H2O2 overwhelms the 
ability of Gpx7/8 and Prdx4 or that something happens in normal squamous 
epithelium of the oesophagus that disrupts or reduces their ability to uti lise and 
reduce H2O2 resulting in its accumulation and in turn oxidative DNA damage.  Some 
evidence for loss of H2O2 protection currently exists with regards to GPx7.  Peng et 
al demonstrated that the GPx7 promoter was silenced by location specific 
methylation in vitro and in vivo mouse models of OAC.  They further demonstrated 
that re-expression of GPx7 in these models led to a reduction in tumour growth and 
an increase in cell senescence and suggest  that GPx7 has a possible tumour 
suppressor role in OAC (Peng, et al., 2014).  The loss of GPx7 has been thought to 
play a major role in the pathogenesis of BO, experiments have shown that loss of 
GPx7 can activate pro inflammatory pathways through activation of NF-κβ via TNF-α 
induction (Peng, et al., 2014). This finding correlates well with evidence that the bile 
salt deoxycholic acid imparts resistance to apoptosis via NF-κβ activation and 
induces ROS/RNS production and DNA damage, particularly double strand breaks in 
tissue biopsies from patients with benign BO (Huo, et al., 2011). Deoxycholic acid 
did not induce DNA damage or activate NF-κβ in normal intestinal cells  (Zhang, et 




the pathogenic transformation of BO to OAC its role in the initial transformation of the 
oesophagus to BO is unclear.   
In addition to evidence linking ERO1-α and the loss of GPx7 with BO and OAC, 
Prdx4 has also been linked with progression in many cancers, such as, breast and 
prostate carcinoma (Rafiei, et al., 2015), primary colon tumours (Leydold, et al., 
2011), glioblastoma multiforme, an aggressive brain malignancy (Kim, et al., 2012)  
and oral cavity squamous cell carcinoma (Chang, et al., 2011).  In particular Prdx4 
seems important in the metastasis of these cancers (Chang, et al., 2011) (Rafiei, et 
al., 2015) and in the silencing of apoptotic pathways (Leydold, et al., 2011) (Wang, et 
al., 2009).  In breast and prostate cancers, it has been observed, by mass 
spectrometry that peroxiredoxins were secreted from the cancer cells.  A meta 
analysis of samples taken from breast and prostate cancer patients determined that 
the gene expression of Prdx4 was increased in carcinoma tissues.  It was also seen 
that patients who developed metastasis had significantly increased expression levels 
of Prdx4 than those who remained metastasis free after 5 years.  The bone is a 
common site of metastasis in breast and prostate cancers (Hess, et al., 2006) and in 
order to release bone-bound growth factors and aid invasive proliferation cancer 
cells must recruit terminally differentiated osteoclasts.  Rafiei et al showed that 
secreted Prdx4 had the capacity to induce osteoclastogenesis and that cell lines 
deficient in Prdx4 demonstrated a decreased ability to stimulate osetoclast formation 
in vitro.  Nude mice, tibial injected with PC3 cancer cells in which Prdx4 had been 
knocked down developed significantly smaller osteoclastic lesions and a decrease in 
osteoclast number compared to control PC3 cells (Rafiei, et al., 2015).  A similar 
finding has also been found in oral cavity squamous cell carcinoma (OSCC) which is 




analysis by Chang et al, showed  differential  expression of Prdx4 when comparing 
metastatic and primary OSSC tumours.  Analysis by immunohistochemistry  
revealed significantly (P <0.0001) higher levels of Prdx4 expression between tumour 
cells and neighbouring epithelial cells and in 31 metastatic lymph node tumours 
compared to corresponding primary tumours (Chang, et al., 2011).  In glioblastoma 
multiformes (GBM),an aggressive brain malignancy, Kim et al found that Prdx4 
expression was unregulated in humans and in mouse GBMs, relating Prdx4 
expression with an increase in ROS. They detected an increase in ROS in mouse 
GBMs, compared to wild type controls suggesting that Prdx4 perhaps helped 
promote GBM growth. In order to test this hypothesis they used a lentiviral, GFP 
tagged expression system to knockdown Prdx4 expression in GBM neurospheres.  
This resulted in an increase in ROS accumulation, DNA damage, an increase in 
apoptotic cell number  and a reduction in GBM growth (Kim, et al., 2012). This 
finding is supported by a small study in colon adenocarcinoma, where Prdx4 was 
also found to be over expressed in tumour cells compared to normal colon tissue.  
Here knockdown of Prdx4 gene expression resulted in an increase in apoptosis 
(Leydold, et al., 2011).  While this increase in apoptosis may be related to its 
antioxidant properties, there is evidence to suggest that over expression of Prdx4 
may actually inhibit part of the apoptotic pathway by downregulating TNF-related 
apoptosis-inducing ligand (TRAIL) independent of ROS production (Wang, et al., 
2009).  Taken together this evidence suggests a significant role for Prdx4 in various 
diverse cancers, it is therefore not a great leap to imagine that disregulation of Prdx4 





1.7 Anterior Gradient 2, an ER resident member of the PDI family which may 
have a role in the pathogenesis of Oesophageal Adenocarcinoma. 
Anterior Gradient 2 (AGR2) is an ER resident member of the PDI super family 
(Persson, et al., 2005) it was first discovered in Xenopus laevis  cement glands 
where it has a role in ectoderm patterning (Aberger, et al., 1998).  In Homo sapiens 
AGR2 has a role in mucus production, particularly the MUC2 mucin in the intestine 
(Bergstrom, et al., 2014) (Park, et al., 2009) and the MUC1 and MUC5AC family 
members (Patel, et al., 2013). Like other ER proteins AGR2 contains a C-terminal 
localisation sequence (Figure 1.5), however rather than the usual KDEL, sequence 
(Munro & Pelham, 1987), AGR2 contains a novel KTEL sequence, Deletion of this 
motif results in AGR2 secretion and loss of AGR2 function (Gupta, et al., 2012). 
Various studies have shown that while AGR2 exists intracellularly it can also be 
secreted (Gupta, et al., 2012), which has important functions related to health and 
disease (Bergstrom, et al., 2014) (Fessart, et al., 2016).  AGR2 contains a single 
thioredoxin fold domain, comprising of a CxxS motif rather than the classical CxxC 
motif (Figure 1.5), suggesting that AGR2 may be a late evolving member of the PDI 
family (Bryctova, et al., 2015) (Persson, et al., 2005).  Recent evidence suggest that 
AGR2 may form dimers through the single cysteine of its CxxS  motif suggesting that 
dimerisation may be required for disulphide exchange between AGR2 and its client 
proteins (Clarke, et al., 2016).  Experiments by Ryu et al have shown both that 
AGR2 interacts with BiP/GRP78 and that dimerisation is required for the interaction 
(Ryu, et al., 2013) although what other client proteins AGR2 interacts with and by 
what mechanism AGR2 facilitates disulphide exchange, if it indeed does, is so far 


















Figure 1.5 AGR2 , Showing the 45aa N-terminal signal sequence, the novel dimerisation motif 
at 60-64aa, the  Cys-81 thioredoxin domain and the C-terminal KTEL motif, (Gupta, et al., 




Other than AGR2s role in disulphide bond formation and the trafficking of large 
cysteine rich glycoproteins, such as the mucin MUC2 (Park, et al., 2009) and MUC1 
and MUC5AC (Patel, et al., 2013) little seems to be known about AGR2's role in 
normal physiology.  Of more importance is the role that AGR2 also has in disease. 
AGR2 appears to have roles in a number of cancers, in particular hormone 
dependant breast and prostate cancer and in  colorectal, pancreatic and gastric 
(hormone independent) cancers (Brychtova, et al., 2011).  As an ER resident protein 
AGR2 has a role in the control of ER homeostasis and its expression is increased as 
part of the unfolded protein response to ER stress (Higa, et al., 2011).  In cancer 
biology AGR2 seems to be involved in a number of processes relating to cell 
adhesion (Patel, et al., 2013) metastasis in oestrogen receptor positive breast cancer 
(Fletcher, et al., 2003) and as a survival factor (Pohler, et al., 2004).  Although in 
breast and prostate cancer increased AGR2 expression seems to be related to 
hormonal stimulation (Bu, et al., 2013) there are several strong links that suggest 
that ER stress plays an important role in AGR2s involvement in cancer.  Experiments 
by Dumartin et al showed that in pancreatic ductal adenocarcinoma (PDAC)  
increased AGR2 expression was present in the early stages of neoplastic 
transformation and as such preceded the development of PDAC. They found that 
discrete subpopulation of AGR2 expressing cells was present neighbouring pre-
neoplastic lesions and that in primary cells from a patient-derived xenograph model, 
that AGR2 was overexpressed in cancer stem cells compared to cancer cells of non-
stem origin.  Further Dunmartin et al saw, in a mouse model, that AGR2 induction 
preceded the development and formation of pre-neoplastic lesions and that deletion 
of AGR2 expression inhibited lesion growth.  They also showed that tunicamycin 




expression in pancreatic intraepithelial neoplasia  persisted after markers of the 
unfolded protein response were switched off (Dumartin, et al., 2016).  How AGR2 
expression is involved in neoplastic transformation is unclear although evidence 
suggests that AGR2 is secreted from that ER (Gupta, et al., 2012) and it is this 
secreted AGR2 that maybe responsible for driving transformation.  Experiments by 
Fessart et al provide some evidence for this, in their study they showed that AGR2 
was present within the extracellular matrix.  Depletion of AGR2 from a lung 
carcinoma cell line resulted in a loss of tumourgenicity and metastatic potential and 
that the addition of recombinant human AGR2 to the media of several 
adenocarcinoma cell lines depleted of AGR2 restored their ability to form tumour 
orgainds.  They also demonstrated the metastatic potential of AGR2.  In vitro normal 
human bronchial epithelial cells (HBEC) form polarised, spherical organids with 
hollow lumens; addition of AGR2 to the extracellular matrix resulted in the formation 
of large non polarised, undifferentiated organids  lacking a lumen. (Fessart, et al., 
2016) suggesting a possible mechanism where, if normally ER localised AGR2, was 
secreted it may be able to induce  tumourgenesis.  
Finally a role for AGR2 has been suggested as a survival factor in cancer, 
particularly in OAC.  A study by Pohler et al showed that AGR2 was overexpressed 
in lysates of BO tissue in comparison to normal oesophageal tissue lysates and that 
overexpression of AGR2 attenuated the phosphorylation of p53, a tumour 
suppressor protein in response to UV induced stress.  However AGR2 does not 
seem to interact directly with p53, so the mechanism by which it suppresses p53 and 
p53 controlled apoptosis is as yet unclear (Pohler, et al., 2004).  It is evident, 
nevertheless, that AGR2 appears to be heavily linked to the pathogenesis of a 




In summary, Barrett's Oesophagus is a complex disease, related to the fact that the 
cells of the oesophagus are under constant environmental pressures, from heat 
stress (due to hot food intake) from chemicals and food products and from exposure 
to refluxed acid, pepsin and bile products.  This scenario is exacerbated further in 
those that suffer from GORD.  Such a complex microenvironment may mean that the 
exact cause of the transition from BO to OAC is individual to each patient, however 
there are many possible targets for biomarker developments that may aid in 
determining the risk of those presenting with Barrett's Oesophagus transitioning to 





1.8 Aims  
There is evidence to suggest a link between the damage caused by ROS such as 
peroxide and oxygen radicals and BO.   Cells and tissues have a system of 
antioxidant proteins and other molecules that prevent damage by ROS, including 
glutathione peroxidases (GPx) and peroxiredoxins (Prdx).  Accumulation of ROS 
may favour the transition of BO to OAC.  Recently, members of the GPx and Prdx 
families have been implicated in controlling protein folding and stress responses in 
the endoplasmic reticulum.  However, the extent to which members of the GPx and 
Prdx families are dysregulated in BO and OAC is not known.  
The aim of the is thesis is to  
 Determine the expression levels of the GPx family member GPx7 and the 
Prdx4 in oesophageal cells.  
 Expose the oesophageal cells to ER stress inducing stimuli and analyse the 
expression profi les of GPx7 and Prdx4  
 To relate any findings to the whole organism the expression of GPx7 and 
Prdx4 in normal oesophageal will be compared with tissue taken from patients 













The following antisera was used, monoclonal antiserum against Prdx4 [7A1](16943) 
and GPx7 [2704](3727) were obtained from Abcam.  A polyclonal GPx7 antiserum 
was a gift from the Yang Group (Wang, et al., 2014)Two antisera against ERp57 
were used the first, ERp57 (G117) was obtained from Cell Signalling and the second 
was a gift from Neil Bullied (Bulleid & Jessop, 2004).  Polyclonal antiserum against 
CANX and CALR was a kind gift from the Okabe Group (Ikawa, et al., 2011).  
Polyclonal Antiserum against BiP (H-129),  antiserum against Insulin (H-86: s-c9168)  
and ERO1-Lα (H-90:sc-98354) were obtained from Santa Cruz Biotechnologies.  
Monoclonal antiserum against AGR2 was obtained from Cell Signalling.  Antiserum 
against PDI (MA3-019) was obtained from Bioreagents and Antiserum against PDIp 
was a kind gift from Michael Lan (Desilva, et al., 1997) 
2.2 Cell Lines  
The following commercial,  immortalised cell lines were used HT1080 (I, Braakman) 
a fibrosarcoma cell line, originally obtained from fibrosarcoma tissue taken by biopsy 
from a 35- year old human male (Rasheed S, 1974) , HeLa (N.Bullied), derived from 
cervical cancer cells (Scherer W, 1953),  OE19 (96071721, ecacc) was derived from 
an Adenocarinoma of Cardia taken from a 72 year old male, OE21 (96062201, 
ecacc) derived from a Squamous carcinoma taken from a 68 year old male and 
OE33 (96070808, ecacc) derived from an Adenocarcinmoa in Barrett's taken from a 







2.3 Cell Culture  
HT1080 cells were maintained in Dublecco's modified Eagle's medium (DMEM 
Gibco Thermofisher Scienti fic), Hela cells were maintained in Minimum Essential 
Medium (MEM, Gibco Thermofisher Scientific ) and OE19 and OE33 cells were 
maintained in Roswell Park Memorial Institute Medium (RPMI 1640 L-glutamine, 
Gibco Thermofisher Scienti fic) all supplemented with 8% Fetal Bovine Serum (FBS, 
Sigma) 2mM glutamax (invitrogen) 100 units/ml penicillin and 100 units/ml 
streptomycin (Invitrogen) at 370C and 5% CO2. All cell lines were serially passaged 
at 70-80% confluency using 0.05% trypsin (Trypsin-EDTA, Invitrogen) to digest the 
monolayer, before resuspending in fresh media Hela and HT1080 cells were typically 
split 1:10 into T75 flasks (TPP Helena Biosciences) and the OE cell lines were 
diluted 2:5 into T25 flasks (TPP Helena Biosciences).  All cell cultures were kept in 
an incubator (Binder) in humid conditions in 5% CO2 (low pressure) at 37
OC.  
2.4 Transfection 
GPx7( Myc-DDK tagged) cDNA (Origene) and the ERO1-α mutant cDNA C394A 
(created by site directed mutagenesis by Dr Adam Benham (Benham, et al., 2000) 
using a Stratagene quick change kit) were used for the transfection of HeLa cells.  
The HeLa cells were cultured, in 6cm culture dishes, containing 3 13mm coverslips,  
to 80% confluence in  Minimum Essential Medium (MEM, Gibco Thermofisher 
Scientific ).  The cells were transfected using Lipofectamine 3000 (Invitrogen, 
Thermofisher).  A master mix was prepared for each cDNA to be transfected, For the 
Gpx7 master mix 2µg Gpx7 cDNA and 4µl p3000 were added to 125µl Opti-MEM 




1µg of C394A cDNA and 4µl p3000 were added to 125µl Opti-MEM.  The 
transfection reagent was prepared in eppendopf tubes each containing 125µl Opti-
MEM and 7.5µl Lipofectamine 3000 and an equal amount of each cDNA master mix 
was then added to each tube which were then left for 5 minutes to incubate before 
adding to the 80% confluent HeLa cells, which were washed twice with 1ml steri le 
PBS before the transfection reagents were added.  Each dish was then left to 
incubate, at 37OC, 5% CO2, for 2 hours after which 1ml of MEM was then added to 
each dish, then left overnight to reach full confluence before analysing by 
Immunofluoresence..   
 
2.5 Cell Lysate Generation 
Cells were lysed in lysis buffer (1 mM phosphate buffered saline (PBS, Sigma) with 
1% Triton X-100 (Sigma), supplemented with 10 µg/ml each of chymostatin, 
leupeptin, antipain and pepstatin A (CLAP) and 20mM N-ethylmaleimide (NEM) 
when required. Nuclei were removed by centrifugation at 16,100g (Eppendorf) for 10 
minutes at 4OC. and the Post-nuclear supernatant collected, flash frozen in liquid 
Nitrogen and stored at -20OC until analysed by SDS-PAGE 
 
2.6 Cell Lysate Protein Quantification   
A PierceTM BCA Protein Assay Kit (Thermo Scientific) was used to determine the 
protein concentration.  The assay kit is a colorimetric detection assay based on the 
biuret reaction, the reduction of Cu2+  to Cu+, with detection and quantification of total 




purple coloured reaction product formed by the chelation of two molecules of BCA to 
one cuprous ion.  This is emits a strong absorbance at 562nm that is nearly linear 
over  a protein concentration range of 20-2000µg/mL.  BSA standards from 25µg/mL 
and 2000µg/ml diluted in lysis buffer (minus CLAP and with or without NEM, sample 
dependant) were prepared in order to generate a standard curve.  Then 0.05mL of 
the  lysate and each standard were combined with 1mL of the Kit's working reagent 
in separate tubes (Eppendorf)  and incubated, in a water bath, at 37OC for 30 
minutes, the tubes were then cooled to room temperature and read on a 
spectrophotometer( Eppendorf  Bio Photometer) at 562nm.  All samples were read 
within 10 minutes as the BCA assay has no true endpoint and so the colour will 
develop further over time.  The standard curve was drawn and lysate concentration 
determined using Microsoft Excel.   
 
2.7 Immunoprecipitation 
 Protein A sepharose beads (Sigma) were prepared by diluting 1:10 of bead slurry in 
lysis buffer.  The beads were spun at 1500g, 5 minutes, 4OC in lysis buffer (without 
NEM or CLAP).  Then the  supernatant was aspirated off and the beads were 
resuspended  in fresh lysis buffer and spun again at 1500g, 5 minutes, 4OC.  The 
supernatant was discarded and the cells were resuspended in 6ul of antibody in lysis 
buffer and incubated for 2 hours at 4OC with rocking.  After incubation the beads 
were spun at 1500g, 5 minutes, 4OC, discarding supernatant, resuspended in lysis 
buffer, then spun again at 1500g, 5 minutes, 4OC.  The supernatant was discarded 
and the beads were then resuspended in a 1:4 dilution of cell lysate in lysis buffer, 




twice at 1500g, 5 minutes, 4OC, discarding supernatant and resuspending in fresh 
lysis buffer between spins.  Finally the supernatant was aspirated off and the bead 
cell mix was resuspended in 50mM DTT in 2x laemmli sample buffer (NuPage LDS 
sample buffer, Invitrogen), heated at 95OC for 5mins, then analysed by SDS-PAGE 
(section 2.10) .   
2.8 Treatments 
In order to observe if any change in protein expression was redox dependant or 
independent, OE19 cells were treated with either under reducing or oxidising 
conditions.  To examine the effects of reducing conditions on protein expression 
OE19 cells were cultured in three 6cm dishes to confluence.  The first dish was kept 
as a control, the culture media was aspirated off and fresh RPMI was added and the 
cells were incubated, at 37OC 5% CO2, for 5 minutes.  The cells were then washed 
once for 5 minutes with PBS with 20mM NEM, then washed once more for 5 minutes 
with just PBS before being lysed.  For dish two the media was aspirated and RPMI 
supplemented with 5mM DTT was added, the cells were then incubated for 5 
minutes then washed, once for 5 minutes with PBS with 20mM NEM, then washed 
once more with just PBS for 5 minutes before being lysed. The final dish was 
aspirated and RPMI supplemented with 5mM DTT was added, the cells were then 
incubated for 5 minutes. The supplemented media was aspirated off and fresh, 
unsupplemented RPMI was added and the cells were incubated for a further 10 
minutes before being washed, once for 5 minutes with PBS with 20mM NEM, then 
washed once more with just PBS for 5 minutes before being lysed.   
To examine the effects of oxidising conditions on protein expression OE19 cells were 




control, the culture media was aspirated off and fresh RPMI was added and the cells 
were incubated, at 37OC 5% CO2, for 5 minutes.  The cells were then washed once 
for 5 minutes with PBS with 20mM NEM, then washed once more for 5 minutes with 
just PBS before being lysed.  For dish two the media was aspirated and RPMI 
supplemented with 5mM Diamine was added, the cells were then incubated for 5 
minutes then washed, once for 5 minutes with PBS with 20mM NEM, then washed 
once more with just PBS for 5 minutes before being lysed. The final dish was 
aspirated and RPMI supplemented with 5mM Diamine was added, the cells were 
then incubated for 5 minutes. The supplemented media was aspirated off and fresh, 
unsupplemented RPMI was added and the cells were incubated for a further 10 
minutes before being washed, once for 5 minutes with PBS with 20mM NEM, then 
washed once more with just PBS for 5 minutes before being lysed. 
2.9 Immunofluoresence  
2.9.1 Standard Protocol 
A 24 well plate was prepared by the addition of a 13mm glass coverslip to each well 
to be used.  The wells were then washed with 500µl PBS.  Cells were culture to 70-
80% confluency  then detached using 0.05% trypsin (Trypsin-EDTA, Invitrogen),  
diluted 1 in 10 with the appropriate media. 500µl of cell suspension was added to 
each well containing a coverslip and then incubated overnight at  37OC, 5% CO2.  to 
allow the cells to adhere to the coverslips 
The media was removed and discarded and the coverslips were washed twice with 
500µl  PBS++ (PBS containing 1mM MgCl2 and 0.5mM CaCl2).  The cells were then 
fixed in 500µl 4% Paraformaldehyde (diluted from 16% stock in dH2O) for 10 




groups were the quenched in 500µl 50mM NH4Cl for 10 minutes then washed three 
more times in 500µl PBS++. The cells were permeablised in 500µl 0.1% Triton X-
100 in PBS++ for exactly 10 minutes, then washed in 500µl PBS++ for 5 minutes.  
then blocked by washing in twice in 500µl BSA (Sigma) in PBS++.   
The blocking solution was fully removed and either 20µl Control (0.2% BSA in 
PBS++) or 20µl of the appropriate primary antibody or a mix of primary antibodies 
from two different host animal species, diluted in PBS++ according to Table 2.1, was 
added to each coverslip,  the plate was then covered and the cells incubated at room 
temperature for 30 minutes, washed three times 5 minutes with 500µl PBS++ before 
incubating in  20µl of the appropriate secondary antibody (Table 2.1),  diluted 1:1000 
in PBS++ for 20 minutes in a dark drawer.  
The coverslips were then washed twice times 5 minutes in 500µl 0.2% PBS++, once 
for 5 minutes in 500µl PBS++ and then for 5 minutes in 40µl 1:1000 DAPI in PBS++ 
all in the dark. The coverslips  were washed a final time in dH2O, to prevent salt build 
up before each coverslip was removed and mounted, cell side down, onto a labelled 
microscope slide using hard set Vectrashield. The slides were left , covered on the 
bench for 20 minutes then transferred to 4OC till set before being examined on a 
Zeiss Apatome microscope.   
2.9.2 Immunofluoresence of AGR2 with Methanol Permeablisation  
A 24 well plate was prepared by the addition of a 13mm glass coverslip to each well 
to be used.  the wells were then washed with 500µl PBS.  Cells were culture to 70-
80% confluency  then detached using 0.05% trypsin (Trypsin-EDTA, Invitrogen),  




each well containing a coverslip and then incubated overnight at  37OC, 5% CO2.  to 
allow the cells to adhere to the coverslips 
The media was removed and discarded and the coverslips were washed twice with 
500µl  PBS++ (PBS containing 1mM MgCl2 and 0.5mM CaCl2).  The cells were then 
fixed in 500µl 4% Paraformaldehyde (diluted from 16% stock in dH2O) for 10 
minutes, then washed three times with 500µl PBS++.  The coverslips were then 
covered with 500µl ice-cold Methanol and incubated at -20OC for 10 minutes, the 
coverslips were then rinsed once in 500µl PBS++ for 5 minutes.   
The cells were then blocked for 1 hour in 500µl Blocking buffer( 5% normal goat 
serum, 0.3% Triton X-100 in PBS++).  The blocking buffer was aspirated off then 
20µl AGR2 antibody, di luted, according to Table 2.1, in 1%BSA, 0.3% Triton X-100 
in PBS++) was added to each coverslip and incubated overnight at 4OC.  After 
primary antibody incubation the coverslips were washed three times for 5 minutes in 
PBS++ before incubating in  20µl of the appropriate secondary antibody(Table 2.1),  
diluted 1:1000 in PBS++ for 20 minutes in a dark drawer.  
The coverslips were then washed twice times 5 minutes in 500µl 0.2% PBS++, once 
for 5 minutes in 500µl PBS++ and then for 5 minutes in 40µl 1:1000 DAPI in PBS++ 
all in the dark. The coverslips  were washed a final time in dH2O, to prevent salt build 
up before each coverslip was removed and mounted, cell side down, onto a labelled 
microscope slide using hard set Vectrashield. The slides were left , covered on the 
bench for 20 minutes then transferred to 4OC till set before being examined on a 





Primary Antibody Host Species Dilution Secondary 
Prdx4 Mouse 1:200 Alexa fluor 488 
GPx7 Rabbit 1:200 Alexa fluor 594 
GPx7 Mouse 1:200 Alexa fluor 488 
erp57 Rabbit 1:200 Alexa fluor 594 
PDI Rabbit 1:200 Alexa fluor 594 
PDI Mouse 1:200 Alexa fluor 488 
CANX Rabbit 1:500 Alexa fluor 594 
CALR Rabbit 1:500 Alexa fluor 594 




2.10 SDS-PAGE  
Post-nuclear supernatants and immunoprecipitates were taken up in 2x laemmli 
sample buffer (NuPage LDS sample buffer, Invitrogen), heated at 95OC for 5mins, 
then analysed by SDS-PAGE.  
Samples were run on an acrylamide gel  containing SDS which comprised of a 
resolving gel and a stacking gel.  The  resolving gel comprised of either 10% or 12% 
Acrylamide (Severn Biotech), percentage dependant on the molecular weight of the 
protein under investigation, 375 M Tris (pH 8.8), 0.1% SDS (Sigma), 0.1% APS 
(Sigma) and 0.04% TEMED (Sigma).  The resolving gel was cast in a  Hoefer gel 
caster system, until polymerised fully, the running gel was covered with dH2O to 
Table 2.1  A List of Primary antibodies used in Immunofluoresence, showing host species, 




ensure that the interface between the running gel and the stacking gel was smooth.  
Once polymerised the dH2O was removed and the stacking gel was added, along 
with a 10 or 15 well comb.  The stacking gel was comprised of 5% Acrylamide 
(Severn Biotech), 0.125 M Tris (pH6.8), 0.1% SDS (Sigma), 0.075% APS (Sigma) 
and 0.075% TEMED (Sigma).  After the stacking gel had polymerised the gel was 
transferred to a mighty small II mini vertical electrophoresis unit and sufficient 1x 
TGS electrophoresis running buffer (10x TGS running buffer (Biorad) diluted with 
dH2O) to cover the gel.  The comb was removed and samples were loaded 
alongside 5 µl of a known molecular weight protein marker (Biorad) All samples were 
equalised to 10µg/ml of protein per well and analysed under either non-reducing 
conditions or reducing conditions, with the addition of 50mM DTT to the sample 
buffer and ran at 50mA unti l the dye front reached the bottom of the gel, without 
running off, then the gel was either Western Blotted or Stained with Coomassie Blue.   
 
2.11 Gel Staining  
The gel was fixed in 50ml of fixing solution (7% Acetic Acid, 40% Methanol in dH2O) 
for 10 minutes. The solution was removed and the gel was covered in Coomassie 
stain (20% Methanol and 80% Brilliant blue G-colloidal concentrate (Thermofisher)). 
The gel was left to stain overnight at room temperature on a rocker, then removed 
and destained with 50ml of destain solution (25% Methanol, 10% Acetic Acid in 
dH2O) for 10 minutes, before removing and destaining, a second time, with 50ml   
25% Methanol in dH2O, overnight, whilst rocking.  The destain was then removed 





2.12 Western Blotting 
Protein's separated by SDS-PAGE were transferred from gel onto  a PVDF 
membrane (Millipore) in transfer buffer (25 mM Tris-Base, 190 mM Glycine in 20% 
methanol). at 150 mA for 2hrs or overnight, at 4OC, at 30V. Prior to use in transfer 
the PVDF membrane was primed in methanol for 20 seconds. Membranes were then 
blocked 5% milk dissolved in TBS-T(10 mM Tris-base, 70 mM NaCl, 1.34 mM KCl, 
0.1% Tween-20, PH 9-9.4) either overnight at 4OC or 1hr at room temperature, with 
rocking.  Membranes were then washed three times, for 5 minutes each, with TBS-T, 
before being incubated in the primary antibody, in 5% milk/TBS-T either overnight, at 
4OC or for 1hr, with rocking. Table 2.2 lists the primary antibodies used, their host 
species and corresponding dilutions.  Membranes were rinsed in TBS-T, then 
washed 4 times, for 5 minutes each, in TBS-T, after which, the membranes were 
incubated with a secondary antibody (DAKO) corresponding to the host animal 
species, see Table 2.2, diluted 1:3000 in 5% milk/TBS-T for 1hr, rinsed in TBS-T, 
then washed 4 times, for 5 minutes each, in TBS-T then once, for 5 minutes, in TBS.  
500µL ECL (Amersham) was then added to the membrane before it was exposed to 









Primary Antibody Host Species Secondary  Dilution 
Prdx4 Mouse GAMPO 1:1000 
GPx7 Rabbit SARPO 1:1000 
GPx7 Mouse GAMPO 1:1000 
ERp57 Rabbit SARPO 1:1000 
PDI Rabbit SARPO 1:1000 
CANX Rabbit SARPO 1:1000 
CALR Rabbit SARPO 1:1000 
AGR2 Rabbit SARPO 1:1000 
 
 
2.13 Molecular Biology 
2.13.1 Transformation of DH5α cells 
DH5α competent cells were transfected with mouse GPx7( Myc-DDK tagged, in 
pCMV6, Figure 2.1)  cDNA (Origene)  for mini prep.  For each transformation  1µl 
GPx7 cDNA (2µg) was heat shocked at 42OC for 1 minute, added to 50µL of DH5α 
competent cells, then incubated at 42OC for another minute.   LB broth (Fisher, 10g 
Tryptone, 5g Yeast extract, 10g NaCl made up to 1l pH7.0)  was then added for a 
total final volume of 1ml and incubated at 37OC for 45 minutes then centrifuged at 
12000 rpm for 1 minute. Supernatant was removed and the cell pellet was re-
suspended in 100µl of LB broth supplemented with 0.25mg/ml Kanamycin and 
spread on LB-agar (Fisher) plates, supplemented with 0.25mg/ml Kanamycin, 
overnight at 37OC.  Single colonies were picked and inoculated, overnight at  37OC, 
with constant agitation, into 5ml of LB broth supplemented with 0.25mg/ml 
Table 2.2 A list of primary antibodies used in Western Blotting, including host animal 




Kanamycin then used to extract plasmid DNA using a Qiagen Mini  Prep kit, 








2.12.2 Mini Prep 
Bacterial cells were harvested by centrifugation at 5400g for 10 minutes at 4OC and 
the cell pellet was then re-suspended in 250µl of Buffer(P1 with added RNase A), in 
a 1.5ml microcentrifuge tube.  250µl of Buffer(P2) was then added and mixed by 
inversion 6 times until the solution became viscous and slightly clear.  Then 350µl 
Buffer(N3) was added and the solution mixed, by inversion, until it became 
colourless.  The solution was then centrifuged at 17,900g for 10 minutes, the 
supernatant was collected, by pipetting, into a QIAprep spin column and spun at 
17,900g for 60 seconds, discarding the flow through.  The spin column was washed 
with 0.75ml of Buffer (PE) and spun at 17,900g for 60 seconds, discarding the flow 
through after which it was spun for a further 60 seconds to remove residual wash 
buffer.  DNA was eluted into a clean 1.5ml microcentrifuge tube, by the addition of  















Figure 2.1 Open Reading Frame (ORF) Nucleotide sequence for Mouse GPx7,  Myc-DDK-tagged at 
the C-terminus of the protein, in pCMV6 (OriGene MR201744) Red=Cloning 




column was placed in the microcentrifuge tube then left to stand for 60 seconds and 
then spun at 17,900g for 60 seconds.  DNA concentration was determined on a 
Labtech Nano-drop spectrophotometer.   
2.13.3 Gel Electrophoresis 
Agarose Gel Electrophoresis was used to identify the presence of GPx7 DNA in 
samples from Mini Prep. A 1% agarose gel was used to run the DNA samples, the 
gel was made from 1.2g Agarose (Invitrogen), 5.5µl ethidium bromide (Fisher)  and 
120ml 0.5x TAE buffer, diluted from a sterile 50x stock solution (60.5g tris base, 
14.3ml glacial acetic acid, 25 µl 0.5M EDTA made up to 250ml with dH2O), each lane 
was loaded with 10µl of sample containing either 1µl 1kb Ladder (Bioline, 
HyperLadderTM1kb)  and 9µl DNAse free H2O; 1µl mini prep sample, 1µl loading 
buffer and 8µl DNase free H2O or a reference sample of 1µl Gpx7 cDNA, 1µl loading 
buffer and 8µl DNase free H2O.  The gel was submerged in TAE buffer and the 
samples were run at 100v for 30 minutes before visualising under UV.    
2.14 Tissues  
Human Pancreatic Tissue was obtained from Medical Solutions PLC.  Normal 
Oesophagus, Gastric, Barrett's Oesophagus and Oesophageal-Gastric Junction 
Tumour Tissue was provided by material transfer agreement from the Department of 








2.15  Immunohistochemistry of human tissue sections 
Paraffin embedded tissue was cut to 4um sections using a microtome, the section 
'ribbons' were floated in a 37oC water bath for a few minutes only, then floated 
sections were lifted out of the water using polylysine coated slides and left to dry 
overnight on a 40oC heat bed.  
2.15.1 Initial Staining Method 
The slides were incubated at 50oC overnight prior to staining then loaded into a 
Thermo Scientific Sequenza Manual Staining Rack. Each section was washed 
sequentially with 120µl the following washes, 7 minute wash in Histoclear (Agar 
Scientific), a second 7 minute wash in Histoclear, a 7 minute wash in 100% ethanol, 
a 5 minute wash in 95% ethanol, a 5 minute wash in 70% ethanol and finally a 3 
minute wash in tap water.  Each section was washed for 15 minute in 3% H2O2 in 
methanol to block endogenous peroxidase activity.   
Slides were then transferred to a rack for antigen recovery and incubated in 10mM 
sodium citrate buffer (pH 6.0) for 20 minutes in a 90oC waterbath, then cooled down 
on ice to room temperature.  Sections were ringed with a hydrophobic pen (Imm 
Edge Pen, Vector Laboratories H-4000)  and 100ul 0.2% BSA in PBS was added to 
each section for 5 minute. Sections were then blocked, for 30 minutes, in 100µl 0.2% 
PBS plus 5% Normal Goat Serum (DAKO) then incubated for 1 hr with 100µl primary 
antibody antibody (antibodies used were the same as those listed in Tables 2.1 and 
2.2) diluted in 0.2% PBS plus 5% Normal Goat Serum. Sections were then washed 
for 5 minutes with 100µl 0.2% BSA in PBS before incubation for 45 minutes with 




by tipping the slide and blotting the edge of each ringed section with tissue then  
washed for 5 minutes with 100µl 0.2% BSA in PBS then incubated for 30 minutes 
with 100µl 1% Reagent A + 1% Reagent B in PBS, prepared 15 minutes prior to 
incubation (DAKO, kit K0492), then washed for 5 minutes in PBS.  DAB solution was 
prepared by dissolving fully 1 H2O2 tablet and 1 DAB tablet (both Sigma) in 5ml PBS) 
then 100µl of DAB-peroxide solution was added to each slide and left for 4 minutes, 
in the dark for 4 minutes, then rinsed in tap water.  Slides were transferred to a slide 
rack and immersed in Harris Haematoxylin (Sigma) for 4 minutes, then transferred to  
tap water for 5 minutes. The slides were then transferred back to the Sequenza 
Staining rack. The sections were rinsed in 2 fast washes of 120µl 1% Conc HCL in 
Methanol.  Then washed twice in 1min washes using 120µl tap water. The sections 
were the washed sequentially with the following washes a fast wash twice in 120µl 
70% ethanol, fast washed twice in 120µl 95% ethanol, washed for 5 minutes in 120µl 
100% ethanol, then washed twice for 7 minutes in 120µl Histoclear.  The sections 
were then mounted in DPX mounting medium and left to dry before examination 
under a Nikon microscope with a lens mounted Euromex CMEX 5mp wireless 
camera. 
2.15.2 Adapted Staining Method  
 
The slides were incubated at 50oC overnight prior to staining then loaded into a 
Thermo Scientific Sequenza Manual Staining Rack. Each section was washed 
sequentially with 120µl the following washes, 7 minute wash in Histoclear (Agar 
Scientific), a second 7 minute wash in Histoclear, a 7 minute wash in 100% ethanol, 




minute wash in tap water.  Each section was washed for 15 minute in 3% H2O2 in 
methanol to block endogenous peroxidase activity.   
Slides were then transferred to a rack for antigen recovery and incubated in 10mM 
sodium citrate buffer (pH 6.0) for 20 minutes in a 90oC waterbath, then cooled down 
on ice to room temperature.  Sections were ringed with a hydrophobic pen (Imm 
Edge Pen, Vector Laboratories H-4000)  and 100ul 0.2% BSA in PBS was added to 
each section for 5 minute.  Sections were then stained using the Vector Laboratories 
RTU Vectastain universal Quick kit (PK-7800).  The sections were transferred to a 
moist chamber and blocked in 100µl  prediluted blocking serum (2.5% Normal Horse 
Serum for 10 minutes, excess serum was then blotted from sections which were then  
washed for 5 minutes in 100µl PBS.   Sections were incubated in 100µl of the 
appropriate primary antibody (antibodies used were the same as those listed in 
Tables 2.1 and 2.2), diluted 1:200 in 0.2% BSA  in PBS containing 1.5% prediluted 
blocking serum for 1hr.  The sections were then washed for 5 minutes in 100µl PBS. 
Following this the sections were then incubated in one drop (~30µl) of prediluted 
biotinylated pan-specific secondary antibody for 10 minutes before washing for 5 
minutes in 100µl PBS and then incubated in one drop of RTU 
streptavidin/peroxidase complex reagent for 5 minutes.  Sections were washed for 5 
minutes in 100µl PBS and  were incubated in 100ul of ImmPACT DAB peroxidase 
substrate (Vector Laboratories SK-4105 consisting of 30ul ImmPACT DAB 
chromogen in 1ml ImmPACT dilutent) for 4 minutes in dark or until desired intensity 
developed then rinsed in  100µl tap water. Slides were transferred to a slide rack and 
immersed in Harris Haematoxylin (Sigma) for 4 minutes, then transferred to  tap 
water for 5 minutes. The slides were then transferred back to the Sequenza Staining 




ethanol, then washed twice in 1min washes using 120µl Scott's tap water substitute 
(41.67 mM NaHCO3 166.16 mM MgSO4 and rinsed in 120 µl dH2O.  The sections 
were then washed sequentially with the following washes a fast wash twice in 120µl 
70% ethanol, fast washed twice in 120µl 95% ethanol, washed for 5 minutes in 120µl 
100% ethanol, then washed twice for 7 minutes in 120µl Histoclear.  The sections 
were then mounted in DPX mounting medium and left to dry before examination 


































Immunohistochemistry  (IHC) is the combination of anatomical, immunological and 
biochemical techniques to identify specific tissue components using the interaction of 
target antigens (tissue proteins) with an appropriately tagged antibody.  Before 
embarking on the staining of the human patient samples, which were kindly provided 
by James Cook University Hospital, it was important to validate the IHC method to 
ensure the best consistency of results.  In principle the IHC method consists of a 
number of discrete steps including sample preparation, tissue permeablisation and 
antigen retrieval,  staining, mounting and finally visualisation.  In order to optimise 
these stages a series of experiments using commercially available pancreatic tissue  
was conducted before work using on the limited patient samples.   
In addition, some antibodies, including those raised against calnexin (CANX) and 
calreticulin (CALR), which had been provided as gifts from the Okabe group (see 
Chapter 2.1), had not been tested on human tissues and their efficacy in 
immunohistochemistry, Immunofluoresence and Western blotting (of human cell 
lines) had yet to be validated 
3.1.1 Histology of the Pancreas  
The majority of the human pancreas consists of exocrine tissue, arranged in lobules 
comprised of pancreatic acinar cells and ductal tissue which drains from the main 
pancreatic duct into the common bile duct (Keshav, 2004).  Pancreatic acinar cells 
have a broad base with a narrow apical surface covered with a few short microvilli.  




secretion of the precursors of a wide range of enzymes.  As such the cells are rich in 
rER located primari ly in the basal half of the cell.  In contrast the apical half of the 
cell can contain a variable number of eosinophilic zymogen granules containing pre-
synthesised enzymes depending on where the cell is in its secretory cycle (Stevens 
& Lowe, 1997).   
In addition to the exocrine pancreatic tissue the pancreas also contains endocrine 
tissue situated in discrete islets throughout the main exocrine tissue, known as the 
Islets of Langerhans.  The Islets of Langerhans are composed of many cell types 
including  β cells, which secrete insulin, α cells which secrete glucagon and D cells 
which secrete somatostatin, the islets do not connect to the pancreatic ductal system 
but instead secrete directly into the bloodstream via an extensive capillary network of 
blood vessels (Keshav, 2004).   
3.1.2 The role of the Calnexin and Calreticulin in the Endoplasmic reticulum.  
Calnexin (CANX) and calreticulin (CALR) are ER resident chaperones, part of the 
lectin family of proteins.  Along with ERp57, a thiol-disulphide oxidoreductase and 
member of the PDI family (Ellgaard & Frickel, 203), CANX and CALR interact with 
and aid in protein folding and disulphide bond formation of newly synthesised N-
linked monogylcosylated glycoproteins that have undergone partial trimming of the 
core glycan (Glc1Man5-9GlcNA2) which is added at the N-terminus of nascent 
polypeptide chains at a side chain containing an Asparagine-X-Serine/Theonine 
sequence during translocation into the ER (Helenius, et al., 1997) (Ellgaard & 
Frickel, 203). CANX is a 65 kDa nonglycosylated type 1 membrane protein 
containing 573aa, which has its substrate binding domain located at the luminal side 




CALR has a KDEL ER retrieval sequence and a C-terminal region with a high 
negative charge, thought to be responsible for ER retention and Ca2+ binding.  
(Helenius, et al., 1997).  
As has been briefly discussed in the introduction, ER resident chaperones and 
components of the oxidative protein folding machinery may have some link in the 
progression of Barrett's Oesophagus (BO) to Oesophageal Adenoncarcinoma 
(OAC). While there is no evidence to suggest that ERp57, CANX and/or CALR are 
involved in OAC there are suggested links that involve ERp57 and CANX in other 
cancers. Dissemond et al demonstrated that, in human metastatic melanoma, there 
was a differential down regulation when comparing CANX and CALR.  They found 
that CANX but not CALR was down regulated in melanoma metastatis, although they 
also observed that this downregulation, while being statistically significant was not 
absolute, in that it was only observed in approximately half of the melanoma cells 
(Dissemond, et al., 2004).  In contrast up regulation of CALR expression has been 
found in invasive ductal breast carcinoma (Kabbage, et al., 2013) (Zamanian, et al., 
2016) where it has been suggested that its up regulation may have an effect on the 
MAPK and p53 pathways (Zamanian, et al., 2016).  Finally there is also a suggestion 
that partial or total loss of ERp57 by hypermethylation of its promoter in  esophageal 
squamous cell carcinoma (ESCC)  may contribute to tumourgenesis (Sheyhidin, et 
al., 2014).  This evidence, taken together, suggested that it was worthwhile to test 
the efficacy of the CANX and CALR antibodies, in range of techniques to be used 








Figure  3.1.  Initial Human Pancreatic Tissue Staining; (EP) Exocrine pancreas (IL) Islets of 
Langerhans (BV) Blood vessel (PD) Pancreatic duct, scale bar represents 200µm, magnification x10.  
(A) and (B) Human pancreas stained against Insulin  (h86) antibody and counterstained with  haematoxylin 
(C) Human pancreas control, 5 minutes DAB development (D) Human pancreas stained against Insulin with 
5 minutes DAB development.  (E)   Human pancreas control, 7 minutes DAB development (F) ) Human 
pancreas stained against Insulin with 7 minutes DAB development (G) Pancreas section with haematoxylin 
staining, bluing  tap water (H) Pancreas section stained with  haematoxylin  staining , blueing with Scott's 
water substitute (I) Pancreas section staining control  with 5 minutes DA B development and  Scott's water 





3.2 Results  
3.2.1Initial tissue staining experiments and method evaluations.   
Initial staining of pancreas was carried out using commercially sourced pancreatic 
tissue stained with the anti insulin H86 antibody as an Islet of Langerhans marker 
and a measure of success, using procedures optimised by Gunasekara et al 
(Gunasekara, 2006).  As can be seen in Figure 3.1 A and B the DAB staining was 
strongest in the islets of Langerhans, as expected, but was also visible more weakly 
throughout the tissue.  Because some background was visible around the Islets of 
Langerhans further experiments were carried out varying the DAB development time.  
For the second set of experiments the DAB incubation time was increased from 4 
minutes to 5 minutes (Figure 3.1C and D) and 7 minutes (Figure 3.1E and F) 
respectively and  the H86 antibody (Figures 3.1D and F) was included alongside a 
negative control (Figures 3.1C and E).  There was little difference in the intensity of 
the DAB staining between the 5 minute DAB developed, H86 stained, pancreatic 
tissue (Figure 3.1D) and the 7 minute DAB developed, H86 stained, pancreatic 
tissue (Figure 3.1F).  However there appeared, in the control tissues (Figures 3.1C 
and E), a loss of the faint blueing from the Haematoxylin counterstain.  Based on 
these observations it was therefore decided that a time of 5 minutes was about 
optimum for DAB development, although with the caveat that this result was only 
demonstrated using the anti insulin H86 antibody on human pancreatic tissue and  
may prove to be primary or secondary antibody dependant and/or tissue specific.  
Of additional note in Figure 3 was the apparent lack of any visible counterstain from 
the Harris Haematoxylin used (see Chapter 2, 2.15.1). Since the blue nuclear stain 




Scott's Tap Water Solution in place of normal tap water (Brown, 2002).  To test this 
pancreatic tissue was stained with haematoxylin then rinsed in either tap water 
(Figure 3.1G) or a solution of Scott's tap water (Figure 3.1H).  From this experiment it 
was apparent that Scott's tap water gave a better staining result and so this was then 
further utilised when co-staining with DAB.  Pancreatic tissue was then stained with 
the h86 antibody, as a positive control (Figure 3.1I) or without H86 (Figure 3.1J) as a 
negative control and compared.  As can be seen in Figure 3 (I and J) the use of 
Scott's tap water gave much better contrast than those previously stained with tap 
water (Figures 3.1A-F).   
3.2.2. CALR is expressed strongly in all cell lines and exhibits a staining 
pattern which suggests that it is predominantly ER localised    
Polyclonal antibodies raised, in Rabbit, against CALR and CANX (see Chapter, 2 
section  2.1) were tested in immunofluoresence.  CALR is an ER localised protein, 
so in order to validate the specificity of CALR in immunofluoresence the cell line 
HT1080 was incubated with CALR as per the standard protocol (see Chapter 2, 
section 2.9.1).  Additionally three different CALR antibody  dilutions were titrated 





                                                                  
Figure 3.2; Expression CALR in HT1080 ,  
OE19 and OE33 cells.  The cells were co-
stained with DAPI (nucleus, Blue) and 
imaged at x63 magnification  with an oil 
drop objective lens, Scale bars represent  
25µm.  (A-C) HT1080 cell line stained with 
different dilutions of the CALR antibody (n=4)  
(A) 1:200  dilution (n=4) (B) 1:500 dilution 
(n=4) and (C) 1:1000  dilution (n=2), secondary 
used Alexa fluor 594 (D) OE19 cell line stained 
with 1:500 CALR dilution (n=2), secondary 
Alexa fluor 488 (E) OE21 cell line stained with 
1:500 CALR dilution (n=2) , secondary Alexa 
fluor 594 (F) OE33 cell line stained  with 1:500 
CALR dilution(n=2) , secondary Alexa fluor 
594) (G) HT1080 cell line stained with 1:200 
PDI dilution (n=4) , secondary Alexa fluor 594.  





and co-stained with DAPI, as a marker of the nucleus (Figure 3.2 A-C and G).  PDI 
shows the classical staining attributed to the ER in Figure 3.2G surrounding the 
DAPI stained nucleus, stained in blue with the PDI localised in the ER seen primarily 
to one side of the cell.  Given that the ER is a continuous membrane system 
interconnected with the nuclear membrane (Schwarz & Blower, 2016) this pattern of 
expression is as expected and demonstrative of ER specific staining.  In comparison 
the expression pattern of the CALR is very similar (Figure 3.2A-C) with a clearly 
defined ER with increased staining localised to one side in a similar manner to that 
observed in PDI stained HT1080 cells (Figure 3.2G). There does however appear to 
be some staining that may be cytoplasmic (indicated by arrows Figure 3.2A-C) .  The 
second purpose of the experiment was to determine the titration of the antibody at 
which consistent results could be obtained. Three dilutions were initially selected, 
1:200 (Figure 3.2A), 1:500 (Figure 3.2B) and 1:1000 (Figure 3.2C). As can be seen 
in Figure 3.2(A-C) all antibody dilutions produced the expected staining pattern. At 
1:200 dilution (Figure 3.2A) the staining appears very intense and there doesn't 
appear to be any non specific staining.  A similar result was obtained with the 1:500 
dilution (Figure 3.2B).  The expression pattern was sti ll clear although it appeared 
less intense. At an antibody dilution of 1:1000 (Figure 3.2C), the expected ER 
staining pattern was visible however the results were not consistent across the slide 
with some cells being more intensely stained than others.  Taken together this 
suggest that a dilution of 1:500 provides a consistent result for use in further 
experiments.  Finally, as oesophageal cell lines were the primary cell type to be used 







Figure 3.3  Detection of CALR in Oesophageal Cell lines, (A) Lysates  from HT1080 and 
from OE21 and OE33 cells were prepared and ran on a 10% SDS-Page gel under reducing 
conditions before transfer to a PVDF membrane and incubation with a 1:1000 dilution of the 
CALR antibody (n=2).  (B) After blotting the membrane was re-probed with PDI  as a loading 
control (C) A second experiment was conducted with OE19 cells, using the same method and 




results could be obtained with the oesophageal cell lines to be used.  OE19 (Figure 
3.2D), OE21 (Figure 3.2E) and OE33 (Figure 3.2F) were also stained with a 1:500 
dilution of the antibody against CALR and compared against PDI (PDI replicates not 
shown).  All three oesophageal cell lines showed a similar expression pattern to that 
observed with the HT1080 cells and  this was comparable to that of PDI in the same 
cell lines, demonstrating that the CALR antibody appeared to detect CALR 
consistently across multiple cell lines.  However, it was noted that some of the 
staining may extend beyond the ER (Figure 3.1A-C and E), this is consistent with the 
suggestion that while CALR is predominantly ER localised there were some foci or 
punctae in some cells, and the relevance of these remains to be investigated 
3.2.3 The CALR antibody gives a strong, well defined signal in Western 
blotting in oesophageal cell lines.   
Experiments from the Okabe group have been performed using CALR on lysates 
taken from sperm collected from the epididymis and vas deferans of mice (Ikawa, et 
al., 2011).  It was therefore important to determine if the antibody would detect the 
presence of CALR when blotted against lysates taken from the human cell lines to 
be used.  Initially only lysates were generated from HT1080, OE21 and OE33 cell 
lines by the standard method (see Chapter 2, 2.5) and equal amounts of protein per 
well were run on a 10% SDS-page gel, under reducing conditions before transfer to 
PVDF membrane.  Membranes were blocked then probed with a 1:1000 dilution of 
the CALR antibody for 1 hour at room Figure 3.3A), developed to see if there was 
any CALR signal and then re-probed with a 1:1000 dilution of an antibody against 
PDI (Figure 3.3B) as a loading control. From the experiment it could be seen that the 
antibody strongly and specifically detected the presence of CALR in all the cell lines 




cells but a re-probe of the membranes with the PDI antibody (Figure 3.3B) showed 
that protein loading may not have been equal across all the lanes.  After the initial 
run of experiments it was decided to include OE19 cells in the analysis.  Lysates 
generated from OE19 cells were, using the same method as used to generate 
lysates from HT1080, OE21 and OE33 cells and ran under the same condition as the 
previous experiment.  The membrane was probed with a 1:1000 dilution of the CALR 
antibody (as used initially) alongside a commercial antibody against ERp57(cell 
signalling G117) (Figure 3.3C).  CALR was detected in the OE19 cell line, although 
the signal was fainter than was previously expected from the other cell lines tested 
(Figure 3.3A).  Erp57 however gave a strong signal suggesting that the poor signal 
from CALR may have been due to an issue with transfer or detection.   
3.2.4. The CALR antibody shows strong expression in the exocrine pancreas 
but not in the Islets of Langerhans.   
Human pancreatic tissue was incubated with a 1:200 dilution of the CALR antibody, 
DAB stained and then co-stained with haematoxylin (Figure 3.4). The overall staining 
was even across the tissue (Figure 3.4A) with CALR protein expression present in 
the glandular cells of the exocrine pancreas but not the islets of Langerhans. This 
result appears to be consistent across all the areas of the tissue viewed (Figure 3.4 
(B-C).  This result compares favourably with data obtained from the human protein 
atlas, which shows medium intensity of CALR staining in the exocrine pancreas and 
no staining in the islets of Langerhans in the majority of the tissue they tested 
(Uhlen, et al., 2017).  In contrast, Omikorede et al showed an significant increase in 
islet CALR expression between lean and obese Zucker rats. They showed very low 
very low levels of CALR expression in lean mice which was significantly increased in 




Figure 3.4 Detection of CALR in Human Pancreatic Sections; Scale bars represent 200µm, (EP) Exocrine Pancreas, (IL) Islets of 
langerhans.   Human pancreas tissue sections were  stained with the antibody against CALR (n=4) and then counterstained with haematoxylin  




This experiment along with the previous Western blotting data and the 
Immunofluoresence experiments suggest that the CALR polyclonal antibody is 
appropriate for Western blotting,  immunofluoresence and in immunohistochemistry 
for the detection of human calreticulin in cell lines and tissues.     
3.2.5. Validation of CANX expression using an antibody previously untested in 
human cell lines and tissues.      
The anti calnexin antibody, also raised in rabbit and provided as a kind gift by the 
Okabe group was also tested. Initial Immunofluoresence experiments were 
conducted with HT1080 cells using three antibody dilutions (1:200, 1:500 and 
1:1000) gave variable results (Figure 3.5), but did confirm that a 1:500 dilution of the 
CANX antibody (Figure 3.5B) was worth investigating further (Figure 3.5D). Going 
forward, it was decided to use a 1:500 dilution of the CANX antibody to test its 
expression in the oesophageal cell lines OE21(Figure 3.6E) and OE33 (Figure 3.6F).  
Expression of CANX in OE21 and OE33 cells was comparable, in most cases with 
that of PDI (Figure 3.6G) and was suggestive of ER staining. There appeared to be 
none of the possible cytoplasmic staining observed with the CALR antibody, which 
was as expected given that CANX is ER membrane bound (Helenius, et al., 1997).  
The titration of the CANX antibody was finally re-visited using OE19 cells (Figure 3.6 
A-C) although the staining pattern was more difficult to see, in OE19 cells due to 







Figure 3.5; HT1080 cells stained with anti CANX antibody and 
imaged at x63 magnification (n=4), at dilutions of 1:200 (n=4) (A), 








Figure 3.6; Expression of a Polyclonal 
antibody against CANX by 
Immunofluoresence and co-stained with 
the nucleus marker DAPI (Blue) , imaged 
at x63 magnification  with an oil drop 
objective lens, Scale bars represent  
25µm.  (A-C) OE19 cell line stained with 
different dilutions of the CANX antibody 
(n=1) (A) 1:200  dilution (B) 1:500 dilution  
and (C) 1:1000 dilution, secondary used 
Alexa fluor 488 (D) HT1080 cell line stained 
with 1:500 CANX dilution, secondary Alexa 
fluor 594  (n=4)(E) OE21 cell line stained 
with 1:500 CANX dilution (n=2), secondary 
Alexa fluor 594 (F) OE33 cell line stained  
with 1:500 CANX dilution (n=2) , secondary 
Alexa fluor 594) (G) Ht1080 cell line stained 
with 1:200 (n=4) PDI dilution , secondary 




The experiment did confirm that, in OE19 cells, CANX appeared to be specifically 
associated with the ER and nuclear membrane and that a 1:500 dilution provided the 
best results,  , although co-staining experiments would be required to determine the 
extent of co-localisation with other ER resident proteins. 
3.3.6 The CANX antibody detects CANX by Western blotting in human 
oesophageal cell lines. 
Like the CALR antibody it was important to determine the behaviour of the CANX 
antibody in Western blotting of lysates of the same cell lines that were tested with the 
CALR antibody.  Therefore, SDS-PAGE was carried out using  the same lysates 
generated from the HT1080, OE21 and OE33 cell lines that were used to examine 
the CALR antibody.  Lysates were run on a 10% gel and proteins were transferred to 
PVDF membrane and blotted with a 1:1000 dilution of the CANX antibody (Figure 
3.7A) developed and then re-probed with a PDI antibody as a loading control (Figure 
3.7B).  Additionally the CANX antibody was also tested using the OE19 cell line at 
the same time as the CALR antibody was tested (Figure 3.7C).  From the first 
experiment (Figure 3.7A and B) it can be seen that the CANX antibody produced a 
well defined signal in all three cell lines: interestingly there appears to be a second 
band, expressed in the OE33 cell lines but apparently absent in the HT1080 and 
OE21 cell lines.  This second band was also seen faintly in the OE19 cell line when 
this was tested (Figure 3.7C).  At first it was thought that this may be an 
experimental error caused by a slipping of the film during exposure to the ECL.  
However when taking into consideration the expression of ERp57 and the single 
band expressed by CALR (Figure 3.3C), which were loaded on the same SDS-page 









Figure 3.7  Detection of CANX in Oesophageal Cell lines, (A) Lysates  from 
HT1080 and from OE21 and OE33 cells were prepared and ran on a 10% SDS-Page 
gel under reducing conditions before transfer to a PVDF membrane and incubation 
with a 1:1000 dilution of the CANX antibody (n=2).  (B) After blotting the membrane 
was re-probed with PDI  as a loading control (C) A second experiment was conducted 
with OE19 cells (n=1), using the same method and conditions before blotting with 





CANX expressed in the OE33 and in OE19 cell lines which is not present in the 
OE21 cell line. The OE21 cell line was derived from an upper oesophageal 
squamous cell carcinoma, where as both the OE19 and OE33 cell lines were 
originally derived from adenocarcinoma cells taken from the lower oesophagus (see 
Chapter 2, 2.2) which may suggest that some form of post translational modification 
occurs to CANX in the OE19 and OE33 cells that doesn't happen in the OE21 cells.    
3.2.7.  CANX  shows strong expression in the human exocrine pancreas  
In the same manner as the tissue sections were stained for CALR (Figure 3.4), 
human pancreatic tissue was incubated with a 1:200 dilution of the CANX antibody, 
DAB stained and then co-stained with haematoxylin (Figure 3.8).  Overall the 
staining was even across the tissue, indicating high expression of CANX particularly 
in the exocrine pancreas (Figure 3.8A).  There was weaker expression in the blood 
vessels (Figure 3.8D), as indicated by lighter staining  and only some of the 
pancreatic ducts appeared to be expressing CANX (Figures 3.8B compared to 
Figure 3.8D).The Islets of Langerhans  appeared  not to be expressing CANX 
(Figure 3.8DC  which is in conflict with the data generated by the human protein 
atlas which suggests that, with the HPA009433 (Sigma), HP009696 (Sigma) and sc-
46669 (Santa Cruz Biotech), antibodies used CANX expression in the Islets 
appeared to be medium to high (Uhlen, et al., 2017).  Comparative staining with 
different CANX antibodies would be required to resolve this issue, but was not within 
the scope of this thesis.   
In summary the both the CALR and CANX antibodies performed well across a range 




 Figure 3.8 Detection of CANX in Human Pancreatic Sections; Scale bars represent 200µm, (EP) Exocrine Pancreas, (IL) Islets of 
langerhans, (BV) Blood vessels, (PD) Pancreatic Ducts.   Human pancreas tissue sections were  stained with the antibody against CANX (n=4) , 
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As was briefly discussed in Chapter 1, there is a possible link between dysfunction of  
ER resident chaperones and the transition of the normal squamous epithelium of the 
oesophagus to BO and ultimately, in some cases, to OAC.    
4.1.1 The Glutathione Peroxidase family in Barrett's Oesophagus. 
 Members of the GPx family of proteins have been shown to have a role in oxidative 
protein folding, disulphide bond formation and the response to stress in the ER 
(Chapter 1.15).  The glutathione peroxidase, GPx8 has been shown to have a role in 
preventing the leakage of ERO1α generated H2O2 from the ER into the cytosol in 
HEK293 cells (Ramming, et al., 2014).  In premalignant BO loss of GPx3 by 
hypermethylation of its promoter region (Lee, et al., 2005) gave rise to an 
accumulation of intracellular ROS which may favour the development of OAC.  
Additionally, there is evidence that GPx7 may be silenced by location specific 
methylation  in OAC (Peng, et al., 2014).  Furthermore GPx7 has been implicated in 
the control of downstream elements of the NF-κβ inflammatory pathway, such that 
down regulation of GPx7 may result in the activation of  NF-κβ signalling via TNF-α 
(Peng, et al., 2014).  There is strong evidence that TNF-α and other NF-κβ mediated 
proinflammatory cytokines, such as IL-8 and IL-1β are elevated in BO and OAC 
(Tselepis, et al., 2002) (O'Riordan, et al., 2005).   
Finally over-expression of GPx7 provided protection against bile acid or H2O2 
induced oxidative stress  in the oesophageal cell lines BAR-T and CP-A and reduced 
oxidative DNA damage and double strand breaks (Peng, et al., 2011).  Further, 
expression of GPx7 may have a role as a tumour suppressor.  Peng et al showed 




oesophageal cell line resulted in an increase in growth, a decrease in the tumour 
suppressors p73, p27, p21 and p16 and an increased deactivation of retinoblastoma 
protein (RB) by phosphorylation.  Conversely the expression of GPx7 in OE33 cells 
resulted in reduced phosphoylated RB and an increase in p73, p27, p21 and p16 
(Peng, et al., 2014).  This evidence suggests that, in BO disruption of the proteins of 
the GPx family may play a role in the pathogenesis of Barrett's Oesophagus and  in 
the transition from stable BO to OAC.   
4.2 Expression of GPx7 in immortalised cell lines   
4.2.1 Immunofluoresence studies of GPx7  
Peng et al claimed that GPx7 was down regulated in BO and OAC (Peng, et al., 
2014). In order to study GPx7 a number of experiments were undertaken.  Initially, a 
panel of immortalised cell lines were stained for GPx7, with PDI as a control, in order 
to determine if GPx7 was expressed and whether that expression was localised to 
the ER (Figure 4.1). All the cell lines used were immortalised cancer cell lines 
derived from different cancer types, HT1080 from a fibrosarcoma, Hela from cervical 
cancer, OE21 from a squamous cell carcinoma of the upper oesophagus, OE33 cells 
from an adenocarcinoma of the lower oesophagus and finally OE19 cells, that were 
derived from an adenocarcinoma of the gastric cardia/oesophageal gastric junction 




Figure 4.1  Cellular Expression of GPx7  by Immunofluoresence, imaged at x63 magnification with an oil drop objective lens.  All antibody dilutions at 1:200, scale bar 
represents 25µm.  (A-C) Ht1080  cells, stained with anti- PDI (A) anti- GPx7 (B) anti-GPx7 costained with anti-PDI (C).  (D-F) Hela cells stained with anti- PDI (D), anti-GPx7 (E) 
anti-GPx7 costained with anti-PDI (C) (n=2).  (G-I) OE21 cells stained with anti- PDI (G), anti-GPx7 (H) anti-GPx7 costained with anti -PDI (I) (n=1).   (J-L) OE19 cells stained with 
anti-PDI (J), anti-GPx7 (K) anti-GPx7 costained with anti-PDI (L) (n=2). (M-O) OE33 cells stained with anti -PDI (M),  anti-GPx7 (N) anti-GPx7 costained with anti-PDI (O) (n=1).  




Each cell line was cultured to 70-80% confluence then stained with a polyclonal 
antibody against PDI with Alexia fluor 488 (green) and a commercial monoclonal 
GPx7 antibody with Alexia fluor 594 (red).  Figure 4.1 shows the results for each cell 
line showing the 488nm wavelength channel, the 594 wavelength channel and a 
composite image.   All the cell lines were positive for PDI expression (Figure 4.1A, D, 
G, J, M) and that expression appeared localised to the ER, with the exception of the 
Hela cell line (Figure 4.1D) where the expression appeared predominantly localised 
to the ER but which also demonstrated a small degree of cytoplasmic staining.  In 
contrast the expression of GPx7 appeared to be nuclear in all the cell lines. which is 
most apparent in the appropriate composite images for each cell line (Figure 4.1C, F, 
I, L, O).  From this series of experiments it appeared that Gpx7 was expressed in all 
cell lines, although in it did not appear to be localised specifically to the ER.  This 
result raises the possibility that the GPx7 antibody  could be detecting a non-specific 
protein or other members of the GPx family.   
4.2.2 Gpx7 could not be detected in cell lines by Western Blotting.  
In order to determine if the antibody was binding specifically to GPx7 cell lysates 
from each cell line were analysed by 10% SDS-PAGE and then blotted for GPx7.  
Initially only HT1080, Hela, OE21 and OE33 cells were assessed (Figure 4.2A).  
According to the manufacturers product data sheet, for the mouse monoclonal 
antibody [2704] ab3727 (Abcam, 2017) an ~20kDa band was expected. Despite 
several attempts there was no detectable band in the HT1080, Hela and OE21 
lysates.  However, in the OE33 lysate several bands were visible at ~55kDa and  









Figure 4.2,  Western Blots of Oesophageal Cell Lines with a 1:1000 GPx7 antibody dilution  10% SDS-PAGE  blotted with  anti - GPx7(HT1080 n=2, Hela 
n=2, OE21 n=2, OE33 n=2) (A) and re-probed with 1:1000 anti-PDI  (n=1) (B) 12%  SDS-PAGE blotted with anti-GPx7(HT1080 n=2, Hela n=2, OE21 n=2, 




Re-probing negative GPx7 negative membranes with anti-PDI indicated that overall 
the transfer was successful (Figure 4.2B).  In order to control for possible fast 
migration of the GPx7 protein, the experiment was repeated using a 12% gel (Figure 
4.2C).  Again there were no visible bands at the 20kDa molecular weight marker, 
however the same 35 and 55 kDa bands appeared in the OE33 lysate as seen in the 
10% gel experiment (compare Figure 4.2A, panel 4, with Figure 4.2C, panel 4). 
Finally an experiment was conducted using OE19 lysates (Figure 4.2C) that had 
been lysed with and without 20mM NEM. This experiment was performed using a 
GPx7 polyclonal antibody gifted by the Wang Group (see Chapter 2, 2.1) (Wang, et 
al., 2014).  Without NEM there was a clear strong band between the 50kDa and 
75kDa molecular markers and faint signals at higher molecular weights. In the 
presence of NEM there was a decrease in the signal compared to the sample 
without NEM, in addition to the faint bands seen at higher molecular weights.  In both 
plus and minus NEM samples there appeared a very slight spots at ~20kDa but it is 
not apparent if this is a true signal or not.   
From the Western blotting data it appeared that GPx7 was not detectable in the cell 
lines tested, despite the abcam antibody giving a strong nuclear staining pattern by 
Immunofluoresence.  This appears to correlate with the published literature from 
Peng et al, which showed that, in OE33 cells, GPx7 expression was suppressed by 
site specific, promoter methylation at the transcriptional level.  (Peng, et al., 2014).  
The appearance of bands at other molecular weights and the data taken from 
Immunofluoresence (see section 4.2.1 and Figure 4.1) strongly suggests that, in the 
absence of GPx7 non-specific binding is occurring.  .  Interestingly, recent data from 
the human protein atlas suggests that GPx7 may have a nucleolar localisation, from 




In order to ascertain if the observed signal seen, in Hela and OE33 cells (and later in 
the OE19 cell line) was non-specific binding, it was decided to transfect Hela cells 
with a GPx7 encoding cDNA, with the goal of analysing GPx7-expressing cells for 
their response to ER and bile acid stress.  Hela cells were transfected (for protocol, 
see Chapter 2, 2.4) with a commercial Myc tagged GPx7 cDNA and along with an 
ERO-1α cDNA mutant (which had previously been successfully transfected into Hela 
cells) as a positive control.  The cells were cultured to 80% confluence, in 6cm 
dishes containing 13mm glass coverslips before transfection with, lipofectamine 
3000, using 2µg of the appropriate cDNA  overnight.  The coverslips were then 
removed, fixed and analysed by Immunofluoresence (Figure 4.3).  Non-transfected 
Hela cells were also imaged for comparison (Figure 4.3D).  In the non-transfected 
cells the distribution of staining appeared non-specific, with background distributed 
throughout the cytoplasm.  The staining in the transfected cells showed a tighter 
distribution, however it didn't appear strongly localised to the ER (Figure 4.3A).  
Staining of the myc tag (Figure 4.3B) showed that the cells had been transfected 
successfully as the presence of the myc was co-localised with that of the observed 
GPx7 staining (Figure 4.3C).  By comparison the Hela cells transfected with ERO-1α 
show staining which appears more ER based (Figure 4.3E) when compared to the 
staining observed in the non-transfected Hela cells (Figure 4.3H).  This is supported 
by the myc tag staining (Figure 4.3G) where there appeared to be myc staining in 
areas where there was no ERO-1α expression.   






Figure 4.3 Hela Cells stained with anti GPx7 antibody and H90 anti ERO-1α antibody at x63 
magnification using an oil  drop objective lens, scale bar represents 25µm (n=1). (A-C) Hela cells 
transfected with myc tagged-GPx7 cDNA (A) transfected cells stained for GPx7 (red) and DAPI (bue) (B) 
transfected cells stained for the myc tag (green) and DAPI (blue) (C) Composite image showing GPx7-
myc-DAPI overlay (D) Non-transfected cells stained for GPx7.  (E-F) Hela cells transfected with myc 
tagged-ERO-1α  cDNA (E) transfected cells stained for ERO-1α  (red) and DAPI (bue) (E) transfected 
cells stained for the myc tag (green) and DAPI (blue) (F) Composite image showing ERO-1α -myc-DAPI 




4.2.3 GPx7 is expressed in leydig cells but was not detectable in human 
pancreas, Barrett's oesophagus or oesophageal, gastric tumour.   
In an attempt to see if GPx7 was increased in BO and in oesophageal cancer human 
tissue was stained to detect GPx7.  It has been suggested that GPx7 expression, 
may be high in the reproductive system (Uhlen, et al., 2017) (Ryser, et al., 2011) and 
so tissue obtained from rat testis was sectioned and stained for GPx7. In addition 
human pancreatic tissue was stained as a negative control alongside the human 
oesophageal tissue and the rat testis as the human protein atlas showed that 
pancreatic expression was low to none (Figure 4.4)  (Uhlen, et al., 2017).   
Pancreatic tissue was stained with DAB and haematoxylin only as a negative control 
(Figure 4.4A), for insulin as a positive control (Figure 4.4B) and for GPx7, using the 
anti-GPx7 antibody obtained from the Yang group (chapter 2.2.1) (Figure 4.4C). As 
expected from the literature (Uhlen, et al., 2017) GPx7 staining was practically non-
existent throughout the pancreatic tissue with a few areas of weak brown staining 
which were likely to be DAB overdevelopment.  The rat testis (Figure 4.4D) showed 
GPx7 expression in both the leydig cells and in the seminiferus ducts which also 
agrees with the literature (Ryser, et al., 2011). In the tissue sample of BO there 
appeared to be no expression of GPx7 in the stratified squamous epithelium (Figure 
4.4E) although there was an indication of slight expression in the lamina propria. 
Other than expression in lymphocytes, which have a high expression of GPx7 
(Uhlen, et al., 2017),  there was a slight indication of GPx7 expression in the tumour 
tissue taken from the oesophageal gastric junction.  However GPx7 did not appear to 
be localised to the tumour cells and may have been in the lamina propria although 




cellular data where GPx7 expression was not detectable in oesophageal cell lines, 
when analysed by Western blotting.   
Taken together there did not appear to be any expression of GPx7 in lysates 
obtained from immortalised cancer cell lines.  Similarly there did not appear to be 
any expression of GPx7 in tissue taken from patient samples of BO.  However, there 
was an indication of expression of GPx7 in the stained rat testis which suggests that 
the antibody obtained from the Yang group could be suitable for visualising GPx7 










Figure 4.4 Expression of GPx7 in rat testis, human pancreas, BO and in an oesophagea l-gastric 
junction tumour.  (BV) blood vessel, (EP)  exocrine pancreas, (PD) pancreatic duct, (IL) islets of 
langerherns, (LC) leydig cells,( LP) lamina propria, (SSE) stratified squamous epithelium (BC) basal 
cell, (DSC) differentiating squamous cell , (TC) tumour cell, (L) lymphocyte.   (A) Human pancreas 
control  x10 magnification (B) Human pancreas stained for insulin using anti h86 antibody x10 
magnification (n=4) (C) Human pancreas stained for GPx7 x10 magnification (n=4) (D) Rat testis 
stained for GPx7 x40 magnification (n=3) (E) Human BO tissue stained for GPx7 x40 magnification 
(n=3) (F) Human oesophageal-gastric junction tumour stained for GPx7 x40 magnification (n=3). 
























5.1 Introduction  
Prdx4 is an ER resident scavenger of H2O2 (Sevier & Kaiser, 2008) which, as 
discussed in Chapter 1, can utilise H2O2 to aid in disulphide bond formation 
(Tavender, et al., 2008).  Prdx4 exists, in the ER, in a decameric form comprising of 
five Prdx4 dimers (Figure 5.1).  Each Prdx4 polypeptide contains a single peroxidatic 
cysteine which can react with peroxide to become sulphenylated.  The sulphenylated 
cysteine can then react with the resolving cysteine on the adjacent Prdx4 
polypeptide in Prdx4 dimer to form a disulphide bond, which is then available to be 
donated to a reduced PDI family member (Bullied & Ellgaard, 2011). It has been 
suggested that, under normal conditions, members of the GPx family are responsible 
for the prevention of H2O2 accumulation from oxidative protein folding within the ER 
and that Prdx4 assisted detoxification only becomes applicable when levels of H2O2  
in the ER are maximised (Ramming, et al., 2014).  As discussed in Chapter 4, in BO 
and OAC there is evidence to suggest that the H2O2 scavenging capacity of the 
GPxs, such as GPx7, is impaired and so it then becomes important to examine how 
the activity and regulation of Prdx4 is affected.   
5.2 Prdx4 expression in oesophageal cell lines  
Initial experiments to validate antibodies and confirm the expression of Prdx4 were 
carried out in the HT1080 cell line using Immunofluoresence.  HT1080 cells were 
cultured to approximately 70% confluence on 13cm glass cover slips, fixed and 
stained with either Prdx4 or PDI, as a positive control (Figure 5.2).  Comparing the 
cells stained with PDI (Figure 5.2A) with those stained for  Prdx4 (Figure 5.2B), 
Prdx4 appeared to be expressed and localised to the ER.  Next lysates from 




analysis of Prdx4 expression by Western blotting (Figure 5.2C) with PDI expression 
as a positive control (Figure 5.2C, lanes 5 and 6).  Initially, no signal could be 
detected Prdx4 but the lanes stained for PDI showed that transfer had been 
successful.  Staining of the membrane with ponceau S (Figure 5.2D), confirmed that 
the transfer had been successful, although some degradation had occurred in the 













Figure 5.1 The Reaction Cycle of Prdx4.  Prdx4 exists as a decamer consisting of 5 dimers (A) Each 
polypeptide in a Prdx4 dimer contains a peroxidatic (per) and a resolving (res) cystine (B) The  peroxidatic 
cysteine reacts with hydrogen peroxide and becomes sulphenylated.  This sulphenylated cysteine can react 
with the adjacent resolving cysteine to form a disulphide bond which in turn can be exchanged with a 
reduced PDI-family member (D) As each Prdx4 polypeptide contains a peroxidatic and resol ving cysteine it 
is possible that a sulphenylated cysteine can react further with hydrogen peroxide forming a sulphenylated 
cysteine on each polypeptide, which can further go on to form two disulphide bonds (C).  adapted from 






Figure 5.2 Prdx4 expression in HT1080 cells (A) Immunofluoresence of HT1080 cells 
stained for PDI, scale bar represents 25 µm (n=2).  (B) Immunofluoresence of HT1080 cells 
stained for Prdx4, scale bar represents 25 µm (n=1).  (C) SDS-page under reducing 
conditions ran on a 10% gel, lanes 2and 3 contain mouse kidney lysate, lanes 5,6,8 and 9 




In order to determine if Prdx4 was expressed in oesophageal cell lines, 
Immunofluoresence was performed on OE19 and OE33 cells (Figure 5.3).  OE19 
cells were stained with PDI (Figure 5.3A) and Prdx4 (Figure 5.3B).  Comparing the 
OE19 cells stained with Prdx4 with those stained with PDI, as a positive marker of 
ER staining, Prdx4 appeared to be localised specifically to the ER.  Comparing 
Prdx4 expression in OE33 cells (Figure 5.3D) with OE33 cells stained for PDI (Figure 
5.3C) again the expression of Prdx4 appeared to be localised specifically to the ER.  
This was similar to the result obtained in HT1080 cells (Figure 5.2).  An OE19 cell 
lysate was run on a 12% polyacrylamide gel under reducing conditions, with and 
without the presence of NEM to trap disulphide bonds.  Prdx4 was detected at the 
expected 25 kDa band (Figure 5.3E) and in addition to this a faint band was detected 
around the 50 kDa marker in the OE19 lysate with NEM.  In order to determine if this 
was a repeatable result, OE19 and OE33 cell lysates were run with and without NEM 
under reducing conditions (Figure 5.3F) and non-reducing conditions (Figure 5.3G).  
It was found that Prdx4 was detected at the expected molecular mass of ~25 kDa in 
the OE19  and OE33 cell lysate, under reducing conditions.  In addition in OE19 cells 
a clearly defined band at ~50kDa and a third band was detected at around 75 kDa 
(Figure 5.3F).  In contrast, the 50 kDa and 25 kDa bands were absent from OE33 
lysates.   
When reduced, by its interaction with H2O2, Prdx4 can bind to PDI to aid disulphide 
bond formation within PDI (Tavender, et al., 2008). It is therefore possible that, in the 
reduced samples, the NEM has trapped the interaction between PDI and Prdx4 







Figure 5.3 Expression of Prdx4 in OE19 and OE33 cells (A) Immunofluoresence of 
OE19 cells stained with PDI (green) and DAPI (blue), scale bar represents 25 µm (n=2).  
(B) Immunofluoresence of OE19 cells stained with Prdx4 (green) and DAPI (blue), scale bar 
represents 25 µm (n=2).  (C) Immunofluoresence of OE33 cells stained with PDI (red) and 
DAPI (blue), scale bar represents 25 µm(n=2).  (D) Immunofluoresence of OE33 cells 
stained with Prdx4 (green) and DAPI (blue), scale bar represents 25 µm(n=2).  (E)  SDS-
page of OE19 cell lysate +/- NEM under reducing conditions (n=1).  (F) SDS-page of OE19 
and OE33 cell lysates +/- NEM under reducing conditions(n=2).  (G) SDS-page of OE19 






Similarly as native Prdx4 exists as a torrid shaped decamer (Tavender, et al., 2008) 
(Wang, et al., 2012), within the ER, the observed bands seen in the non-reducing 
gel, in the presence of NEM, could possibly be trapped in a reaction intermediate 
(possibly a dimer).   
5.3 Expression of Prdx4 in human tissue 
With the observed expression of Prdx4 in the oesophageal cell line models of BO 
and OAC it was important to see if expression could be detected in human tissue 
samples of BO and OAC, compared to samples taken from normal oesophageal and 
gastric tissues.  Samples of normal oesophagus, normal gastric, BO tissue and 
tissue taken from an oesophageal gastric junction tumour were therefore 
immunohistochemically stained for Prdx4.  In addition, as pancreatic expression of 
Prdx4 is high (Uhlen, et al., 2017), human pancreatic tissue was also stained as a 
positive control (Figure 5.4).  As expected, in the pancreatic, expression of Prdx4 
was high in the exocrine pancreas and low to none in the Islets of langerhans tissue 
(Figure 5.4A).  Prdx4 was expressed in the normal oesophageal tissue (Figure 5.4C) 
compared to control (Figure 5.4 B) however expression appeared low when 
comparing it to the Prdx4 expression in normal gastric tissue (Figure 5.4D).  In the 
patient samples of BO there was a disparity in the level of staining between those 
areas which had the appearance of squamous epithelium and those which contained 
cells with the morphology of gastric columnar cells (Figure 5.4E and F). This 
appeared consistent between different samples, allowing for between patient 










Figure 5.4 Human Tissue expression of Prdx4.  (A) Human Pancreas stained for Prx4 (n=3). 
(B) Normal oesophagus control, (C) Normal oesophageal tissue stained for Prdx4 (n=2).  (D) 
Normal gastric tissue stained for Prdx4 (n=2).  (E and F) BO tissue from two separate patient 
samples, boxed area indicates presence of gastric -like glandular tissue (n=2).  (G and H) 
Oesophageal-gastric-junction- tumour from two separate patient samples . (n=2).  Key  (IL) 
Islets of Langerhans (EP) Exocrine pancreas (SSE) Stratified squamous epithelium (LP) Lamina 
propria (BC) Basal cell (DSC) Differentiating squamous cell (SCE) Stratified columnar epithelium 







 In the tissue samples taken from patients with an oesophageal-gastric-junction-
tumour (Figure 5.4 G and H) the pattern of staining appeared inconsistent, there was 
evidence that some areas may have a darker staining, which may indicate localised 
areas of increased Prdx4 expression, however this wasn't clear in one of the patient 
samples (Figure 5.4G). In another sample, however, there were clearly observable 
areas of staining, possibly indicating areas with high expression of Prdx4 (Figure 
5.4H).  This correlates with the observations that Prdx4 expression in breast and 
prostate cancers is increased in areas of carcinoma compared to non-tumour tissue 
(Hess, et al., 2006). Similar increases in Prdx4 expression have also been found in 
Oral Cavity Squamous Cell Carcinoma and in Glioblastoma multiformes, an 
aggressive brain malignancy (Chang, et al., 2011) (Kim, et al., 2012).   
Taken together, the data suggest that Prdx4 expression is worth pursuing as a 



















6.1 Introduction  
Anterior Gradient 2 (AGR2) is a member of the PDI family. Over expression of AGR2 
has been linked to various roles in a number of cancers, as discussed in Chapter 1 
(Chapter 1.16), reviewed in (Brychtova, et al., 2011).  Research into AGR2 has 
suggested that it may also have a role in BO and its transformation into OAC through 
the silencing of the tumour suppressor p53 (Pohler, et al., 2004).   
AGR2 is involved in the production of intestinal mucus (Park, et al., 2009) and has 
been linked to the response to stress in the ER (Zweitzig, et al., 2007) (Zhao, et al., 
2010).  Research has shown that AGR2 can interact with BiP/GRP78 and that this 
interaction is dependent on AGR2 dimerisation (Ryu, et al., 2013).  However, the 
exact role that AGR2 has in the ER stress response is unclear.  There is also 
evidence to suggest that it may also form complexes with other ER resident proteins 
either as a monomer or as an interaction between a target protein and its homodimer 
(Clarke, et al., 2016).   
6.2 AGR2 Expression in Human Tissue Sections 
Tissue blocks of normal oesophageal, normal gastric, BO and OAC from human 
patients, were sectioned, mounted on polarised microscope slides and then stained 
for AGR2 (Figure 6.1).   AGR2 was present in normal gastric tissue, in the columnar 
glandular cells (Figure 6.1B) but was not present in normal oesophageal tissue 
(Figure 6.1A).  The tissue sections taken from the oesophagus of patients presenting 
with BO (Figures 6.1C and 6.1D) show a mixed morphology with the presence of 
gastric columnar cells (Figure 6.1C) and glandular tissue (Figure 6.1D).  AGR2 
expression appeared high in the columnar glandular cells (Figure 6.1C) and in the 
























Figure 6.1 Histological Staining of Human Tissue Sections with 1:200 anti AGR2 antibody at x10 magnification, Scale bars represent 200µm   
(A) Normal Human Oesophagus stained for AGR2 (n=4).  (B) Normal Gastric tissue stained for AGR2(n=4).  (C) Barrett's Oesophagus tissue stained for 
AGR2 (n=2), (D) Barrett's Oesophagus tissue stained for AGR2 (n=2),  (E) Oesophageal-Gastric Junction Tumour tissue stained for AGR2 (n=1). (F) 
Oesophageal-Gastric Junction Tumour tissue stained for AGR2 (n=1).  (SSE) Stratified squamous epithelium (LP) Lamina propria (BC) Basal Cell (DSC) 
Differentiating squamous cells. (GC).  Glandular cells (Simple columnar epithelium).  (G) Glands.  (OAC) Oesophageal adenocarcinoma.  BO tissue and 





epithelium (Figures 6.1C and 6.1D).  In the tissue sections taken from patients 
presenting with OAC (Figures 6.1E and 6.1F), AGR2 expression appears confined to 
the glandular cells overall however there is some suggestion of AGR2 expression in 
the undifferentiated cellular region of one of the samples (Figure 6.1F).  
From the experiment it appears that AGR2 is expressed in the columnar epithelium 
of gastric tissue but not normally expressed in the oesophagus, consistent with the 
literature.  In comparison AGR2, in BO, is only expressed where the squamous 
epithelium has transitioned into glands or columnar epithelium.  This is probably due 
to AGR2's involvement in the production of mucus.  In the samples of OAC, AGR2 is 
expressed mostly in the columnar cells but there is some suggestion that AGR2 may 
also be expressed in the tumour mass.   
6.3 Expression of AGR2 in Oesophageal cell lines 
In order to determine if AGR2 was also expressed in oesophageal cell lines.  OE19 
and OE33 cells were cultured to approximately 70% confluence, on 13mm glass 
cover slips.  The cells were then fixed with 4% paraformaldehyde and then 
permeablised in ice cold methanol before blocking for an hour and then incubated 
overnight at 4oC with either an anti-AGR2 antibody or PDI antibody as a positive 
control of ER localisation.  Each coverslip was then incubated with an appropriate 
fluorescent secondary antibody and co-stained with DAPI (Figure 6.2).  Comparing 
OE19 cells stained with AGR2 (Figure 6.2B) to OE19 cells stained with anti PDI 
(Figure 6.2A) showed that, in OE19 cells, AGR2 is localised to the ER.  In 
comparison the expression of AGR2 in OE33 cells was only present in a few cells 




the characteristic ER staining shown in the OE19 cells stained with the anti PDI 










Figure 6.2 Expression of AGR2 in oesophageal cell lines.  OE19 and OE33 cells stained 
with either anti AGR2 or anti PDI antibody.  (A) OE19 cells stained for PDI (n=2) (B) OE19 
cells stained for AGR2 (n=2) (C) OE33 cells stained for PDI (n=2) (D) OE33 cells stained for 




Comparing the expression of AGR2 between the OE19 and OE33 cell lines showed 
that the expression of AGR2 was strongly expressed in the OE19 cell line (Figure 
6.2B) compared to OE33 cells (Figure 6.2D). In the OE19 cell line AGR2 was 
expressed in each cell where as in the OE33 cell line only a very small amount of 
cells appeared to be expressing observable amounts of AGR2.  
To investigate this further cell lysates of OE19 and OE33 cells were separated by 
SDS-PAGE under reducing conditions and Western blotted with an anti-AGR2 
antibody (Figure 6.3A).  The OE19 cell lysate showed a good signal at the expected 
molecular weight which was absent in the OE33 lysate.  Based on this result, the 
SDS-PAGE was repeated, using OE19 cell lysate,  under both reducing and non-
reducing conditions.  To explore whether AGR2 formed any complexes with other 
proteins OE19 cell lysates were run with or without NEM to preserve disulphide 
bonds (Figure 6.3B).  Under reducing conditions, without NEM, the result of the 
experiment was similar that seen in Figure 6.3B lanes 1 and 2.  Under non-reducing 
conditions, without NEM, only the expected bands appeared (Figure 6.3B lanes 5 
and 6).  However in the samples with NEM bands are visible at 37 kDa, ~50 kDa and 
around the 75 kDa molecular marker (Figure 6.3B lanes 7 and 8).  In the samples 
run under non-reducing conditions, with NEM, the band seen at 37 kDa could 
possibly be AGR2 in a dimeric form, as seen by Ryu et al and if so then it is possible 





















   1                 2             3               4                     5             6               7             8 
Figure 6.3 SDS-PAGE and Western blotting of AGR2 in oesophageal cell lines.  A,  
OE19 and OE33 lysates run on a 12% gel under reducing conditions (n=2).  B,  OE19 
lysates run under reducing conditions without NEM (lanes 1 and 2) and with NEM (lanes 
3 and 4) and run under non-reducing conditions, without NEM (lanes 5 and 6) and with 




However the presence of more bands than those previously seen suggests that 
AGR2 can form multiple complexes with other ER resident proteins.   
In order to determine if the observed AGR2 interactions were redox dependent OE19 
cells were cultured to confluence and then treated with redox modifying reagents.  
To establish reducing conditions, OE19 cells were cultured in three 6cm dishes, one 
dish was used as a control, one was treated with 5mM DTT and one dish was first 
treated with 5mM DTT for 5 minutes then washed and incubated in media for a 
further 10 minutes.  This was done to see if removal of the reducing conditions 
resulted in a return to the control state, which would indicate that the complex 
formation was reduction dependant.  Similarly the experiment was repeated under 
oxidising conditions with 5mM Diamide to determine if the complex formation was 
oxidation dependant. After each treatment, including the control, samples were 
washed with 20mM NEM  for 5 minutes, to preserve any disulphide bonds then lysed 
and analysed by SDS-PAGE under non-reducing conditions  with NEM (Figure 6.4).   
In the Western blot of the samples under reducing conditions (Figure 6.4A), the 
control samples exhibited a similar pattern of bands as previously seen (Figure 
6.3B).  These bands disappeared when the OE19 cells were treated with  5mM DTT 
leaving only the main AGR2 monomer band.  When OE19 cells were treated with  
5mM DTT and then allowed to recover by incubation for a further 10 minutes with 
untreated media there was a noticeable return of some of the extra bands.  The 
disappearance and then recovery strongly suggests that the interactions disulphide 
















Figure 6.4 SDS-PAGE and Western blot analysis of AGR2 in cells treated with redox 
reagents  A OE19 cells were either washed then incubated  with media as a control (Ctrl) , 
incubated with 5mM DTT or incubated with 5mM DTT then washed and incubated for a further 10 
minutes with untreated media (DTT R) (n=2).  and B OE19 cells were either washed then 
incubated  with media as a control (Ctrl) , incubated with 5mM Diamide (DIA) or incubated with 
5mM Diamide  then washed and incubated for a further 10 minutes with untreated media (DIA R) 




The experiment was then repeated with Diamide as an oxidation agent (Figure 
6.4B).  Examination of the Western blot showed a similar control pattern of bands 
however they were fainter than seen in the previous experiment.  The addition of 
5mM Diamide to OE19 cells clearly showed an increase in the number and signal 
strength of the extra bands.  Allowing the OE19 cells to recover for 10 minutes after 
Diamide treatment showed a return to the band pattern seen in the control, with the 
exception of a strong band at 100 (Figure 6.4B).  This suggests that oxidation 
increases the formation of extra bands.   
These experiments demonstrate that the observed extra bands are redox dependant 
and that these extra bands represent AGR2 complex formation.  This suggests that 
the ability of AGR2 to form complexes with other proteins is  redox dependant and 
suggests a role for AGR2 in oxidative protein folding despite the lack of a 
conventional CGHC motif in the a domain   
PDI is involved in oxidative protein folding pathways in the ER.  It was therefore 
logical to see if it was one of the client proteins that complexed with AGR2.  To 
investigate this an immunoprecipitation was prepared.  Protein A sepharose beads 
were incubated with anti-PDI antibody before immunoprecipitating PDI from OE19 
cell lysate. The bead-lysate mixture was centrifuged, washed and the beads 
collected in sample buffer, as detailed in Chapter 2.2.7.  The immunoprecipitate  was 
then analysed by SDS-PAGE, on a 12% polyacrylamide gel under reducing 
conditions, without NEM, alongside a mixture of lysate, anti-PDI antibody (MA3-019, 
Bioreagents) and beads and input OE19 lysate (Figure 6.5) prior to Western blotting 






















Figure 6.5 Immunoprecipitation of OE19 cell lysates.   
OE19 cell lysate incubated with Protein A sepharose beads 
and 6ul anti-PDI antibody in PBS lysate buffer (IP).  A Mix 
of OE19 lysate, anti-PDI antibody and sepharose beads 
(Mix).  Untreated OE19 lysate (UT) were ran, under 
reducing conditions, without NEM, on a 12% acrylamide gel 




AGR2 was detected in the untreated lane as expected but was not present in the mix 
or IP lanes (Figure 6.5) suggesting that, based on this experiment,  PDI and AGR2 
do not form detectable complexes in the ER.   
In summary AGR2 was found to be expressed in normal gastric tissue but not in the 
normal oesophagus. AGR2 expression in patient samples of BO was  found to be 
confined areas that had undergone the transformed into gastric like tissue.  In OAC, 
AGR2 expression was found both inside and closely associated with the tumour 
mass which could suggest that, in OAC, the tumour produces and secretes AGR2.  
Examining AGR2 expression in oesophageal cell lines, AGR2 was detected in OE19 
cells but not in OE33 cells, when analysed by Western blotting.  In 
immunofluoresence, AGR2 was found to be expressed strongly in the ER of OE19 
cells.  In OE33 cells, AGR2 expression was only seen in a few cells and did not 
appear to show classical ER expression.  This suggests that AGR2 expression may 
occur in OE33 cells but at a level that wasn't detectable in Western blotting.  In OE19 
cell lines AGR2 was shown to form high molecular weight disulphides, under non 
reducing conditions, in the presence of NEM.  Further analysis of OE19 cells under 
redox conditions showed that the high molecular weight disulphides were redox 
dependant, suggesting that AGR2 may have a role in redox poise and perhaps 
























This study was based on the hypothesis that ER stress leads to the dysregulation of 
ER redox/protein folding networks in the oesophagus and that this ER dysregulation  
may play an important part in the disease BO and its transition to OAC. 
Initial experiments focused on the proteins GPx7 and Prdx4 which play a role in both 
protein folding, via the ERO1-PDI pathway and in protecting the ER from ROS, a by-
product of ERO1-PDI protein folding (Nguyen, et al., 2011) (Chen, et al., 2016). This 
was followed by the examination of  AGR2, a member of the PDI family of proteins, 
which, due to its possible involvement in various cancers (Brychtova, et al., 2011), 
became a promising candidate for research into the transition of the oesophagus to 
BO and in some patients OAC.   
Experimentally, some improvements could be made in the way the study was carried 
out to improve the weight of the results.  The Western blotting experiments would 
benefit from more consistency, such that each blot should have followed the same 
format of reducing/non-reducing and +/-NEM.  In addition each blot should have 
included PDI as a positive control and been re-probed with Actin   
Similarly the controls for the Immunohistochemistry experiments could be improved. 
Initially pancreatic tissue was stained against insulin with an h86 antibody as a 
positive control. This should have been continued forward with all subsequent 
experiments.  In relation to the AGR2 study,  if the study was repeated, it would 
benefit from the inclusion of a negative control of to highlight any issues with 
overdevelopment.  Suitable negative controls would be human tissue taken from the 
brain, muscle, adipose or skin which have low expression scores of AGR2, 




7.2 The Expression of GPx7 in the ER, BO and OAC 
GPx7 has a role as a scavenger of H2O2 in the ER and can uti lise H2O2 in oxidative 
protein folding in concert with ERO1α and PDI (Nguyen, et al., 2011). Evidence from 
literature suggested that GPx7 may play a role in the pathogenesis of BO and OAC.  
Experiments with GPx7 had showed that it had a protective role in preventing 
oxidative DNA damage in oesophageal cells (Peng, et al., 2011) and that it had 
tumour suppressor capabilities which were down regulated in cancer cells by 
location specific methylation of the GPx7 promoter region (Peng, et al., 2014). 
Immunofluoresence of  the cell lines HT1080, OE19, OE21 and OE33 showed some 
expression of GPx7 but this expression did not appear to be specifically localised to 
the ER when compared to PDI. In this thesis Western blotting of cell lysates taken 
from HT1080, OE19, OE21,OE33 and HeLa cells failed to show any expression of 
GPx7 at the expected molecular weight on the manufacturers data sheet.  A likely 
non specific signal was seen in some experiments, for example in an OE33 cell 
lysate: but this signal was at a higher molecular weight than expected (Figure 4.2).  
The GPx7 antibody reactivity towards OE19 cell lysates were similar to the OE33 cell 
lysates, in that multiple bands could be seen at higher molecular weights but not at 
the expected molecular weight for GPx7.  Considering the experimental data from 
both Western blotting and immunofluoresence together they seem to suggest that 
there was some non specific binding with the antibody and a lack of GPx7 
expression.  The likely lack of expression correlated well with the evidence that 
GPx7 is suppressed in cancer derived cell lines as described in the literature.  
Further experiments to determine the effects of ER stress on GPx7 expression would 
either require a transfection approach, the verification of  GPx7 specific antibody, 




been suggested to express GPx7.  For example, Peng  et al had shown baseline 
expression of GPx7 in Western Blotting of BAR-T, HET1-A, EPC2 and CP-A cells ( 
(Peng, et al., 2011) supplementary data, figure 1) 
Human tissue samples of BO and OAC were kindly provided by James Cook 
University Hospital and stained for GPx7 to determine if there was any correlation 
between tissue expression of GPx7 and the results seen in the cell line experiments.   
In the tissue samples of BO it appeared that GPx7 may be expressed in the lamina 
propria but there was no expression observed in the epithelial layer. In tissue taken 
from patients with OAC there appeared to be a small amount of expression which 
was located close but did not appear to be associated with tumour cells.  Given the 
disordered nature of the tissue, expression could equally be from another cell type, 
such as gastric-like columnar cells rather than a tumour cell. In situ hybridisation or 
another complementary approach would be required to confirm GPx7 expression in 
this tissue. 
GPx8 is homologous to GPx7 and merits further examination, in the context of this 
study.  GPx8 is thought to perform a similar role to GPx7 in the ER, except that 
GPx7 is soluble in the ER lumen and GPx8 is membrane bound and localised to the 
inside of the ER membrane (Chen, et al., 2016).  GPx8 has also been shown to have 
a higher expression level than GPx7 (Nguyen, et al., 2011). In tissue, GPx8 is 
expressed in the digestive system.  The Human Tissue Atlas shows mixed, possibly 
tissue and/or antibody dependent, expression of GPx8 in the oesophagus and high 
expression in the stomach (Uhlen, et al., 2017).  Therefore it may be possible 




If oxidative stress leads to redox dysfunction and dysregulation of the ER protein 
folding networks then, logically, something may also affect the H2O2  scavenging 
capacity of GPx8.  As GPx8 performs a role in preventing the leakage of H2O2 from 
the ER (Ramming, et al., 2014) then dysfunction of GPx8 in BO could result in 
peroxide induced DNA damage (Figure 7.1) and ultimately cause the transition from 
















                                                                                                    
 




























Figure 7.1.  Under normal conditions GPx8 prevents the leakage of H2O2 from the ER.  
The disruption of GPx8 would allow the leakage of H2O2 which could result in Oxidative 






7.3 Expression of Prdx4  
Like GPx7, Prdx4 is an H2O2 scavenger in the ER.  Prdx4 can also aid in disulphide 
bond formation with PDI catalysing oxidative protein folding (Tavender, et al., 2008).  
It is thought that GPx protein's are the main removers of the excess  H2O2 produced 
by oxidative protein folding in the ER and that Prdx4 only fulfils that role when levels 
of H2O2  are maximised (Ramming, et al., 2014).  As such the study of Prdx4 
becomes important in BO, given the evidence that GPx7 may be down regulated in 
BO (Peng, et al., 2014).   
OE19 and OE33 cells were both shown to express Prdx4 by imunofluoresence and 
Western blot (Figure 5.3). There were observable differences in the expression of 
Prdx4 between OE33 and OE19 cells.  In OE33 cells expression of Prdx4 seemed 
less tightly restricted to the ER then in OE19 cells.  Western blotting of OE33 and 
OE19 lysates under reducing conditions showed expression of Prdx4 at the 
expected molecular weight and also showed bands at higher molecular weights 
suggesting that there may be a difference in redox poise between OE19 and "the 
more advanced" OE33 cells.  Prdx4 has been shown to form decameric complexes 
(Tavender, et al., 2008), so under reducing conditions it is possible that the presence 
of NEM has trapped Prdx4 in a number of different states. Under non-reducing 
conditions, in the presence of NEM, Prdx4 may be trapped as a decamer.  
Interestingly there appeared to be a greater expression of Prdx4 in OE19 cell lysates 
compared to OE33 cell lysates, although whether the expression differences are 
reproducible requires further experiments.  Both cell lines were originally derived 
from primary OAC tumour, with the OE19 cell line derived from a tumour at the 
oesophageal-gastric junction.  While the OE33 cell line was originally derived from a 




possibly suggests that cells located nearer the oesophageal-gastric junction, which 
would be more likely to experience an increased exposure to acid, may be more 
likely to express an increased Prdx4.   
In human tissue sections stained for Prdx4, Prdx4 appeared to be expressed higher 
in normal gastric tissue than in normal oesophageal tissue.  In stained samples of 
BO tissue Prdx4 expression did appear higher in areas containing gastric like cells 
compared to the areas containing squamous epithelium (Figure 5.4).  This may 
possibly correlate with the differences observed between OE19 and OE33 cells 
which suggests that Prdx4 expression may be linked to the amount of gastric like 
cells in the area of BO.  
Prdx4 expression in tissue taken from oesophageal gastric junction tumours differed 
between samples with some sections showing little to no expression of Prdx4 and 
some sections showing localised areas of staining in or near tumour cells.  Prdx4 
expression has been linked to a number of cancers.  Prdx4 expression has been 
observed to be increased in areas of carcinoma, in breast and prostate  cancers, 
compared to non-tumour tissue (Hess, et al., 2006). Similar increases in Prdx4 
expression have also been found in Oral Cavity Squamous Cell Carcinoma and in 
Glioblastoma multiformes, an aggressive brain malignancy (Chang, et al., 2011) 
(Kim, et al., 2012). Additionally there is evidence that secreted Prdx4 may also be a 
factor in tumourgenesis.  Secreted Prdx4 has been linked to cancer induced 
osteoclastogenesis (Rafiei, et al., 2015) suggesting that over expression of Prdx4 
may be a factor in the transition of BO to OAC.   
Immunohistochemistry, from the experiments, in this thesis, suggests that normal 




true in HET-1A or EPC2 cells.  If so then it would be worthwhile subjecting those cell 
lines to stress e.g. peroxide and/or a bi le acid cocktail alongside OE19 and OE33 
cells to determine if they give the same response and to see if less or more stress is 
needed to cause Prdx4 expression to rise above baseline.  Expression analysis 
could be done at both mRNA level and protein level.  It may also be worth testing the 
media of the cell lines, particularly under stress conditions to see if any Prdx4 is 
secreted in response to stress conditions.    
7.4 Expression of AGR2  
AGR2 is an member of the PDI protein family.  It is localised to the ER by a C-
terminal KTEL motif, similar to the KDEL and KVEL ER retention sequences (Gupta, 
et al., 2012). Like PDI, AGR2 contains thioredoxin like domain which could indicate a 
role for AGR2 in oxidative protein folding.  However, unlike PDI, AGR2 contain a 
single redox active cysteine residue (Galligan & Peterson, 2012) suggesting that if it 
is involved in disulphide bond formation it may be via an unconventional route.   
Analysis by mass spectrometry has shown that AGR2 can dimerise by forming a 
disulphide bond with itself (Clarke, et al., 2016).   
The experiments in Chapter 6, Figures 6.2 and 6.3, showed that AGR2 is expressed 
in both OE19 and OE33 cells.  In OE19 cells AGR2 appears to be wholly expressed 
in the ER but in OE33 cells there was a suggestion that AGR2 was not wholly 
confined to the ER.  There is evidence to suggest that AGR2s novel KTEL motif may 
allow it to be secreted (Fessart, et al., 2016) so it is plausible that, in OE33 cells, 
some AGR2 is secreted.  Comparing OE19 cells and OE33 cells, AGR2 appeared to 




analysis of lysates taken from OE19 and OE33 cells appear to support this where 
AGR2 was detected in OE19 lysates but not in OE33 cells in reduced samples.   
Further examination of AGR2 expression in OE19 lysates showed clearly that, under 
non reducing conditions, AGR2 can form a dimer.  In addition detection of multiple 
bands in non reduced samples, in the presence of NEM, suggest that AGR2 is also 
capable of binding to other proteins reinforcing the idea that AGR2 may be involved 
in the in protein folding.  Further experiments support this assertion, for example the  
treatment of OE19 cells with DTT showed a reduction of all AGR2-client interactions, 
including the reduction of dimers to monomers. A DTT washout and recovery 
experiment showed that after recovery the AGR2 dimer and other AGR2-protein 
interactions returned to the control status (Figure 6.4).  Diamide cause an increase in 
AGR2-client interactions which, when allowed to recover, returned towards baseline 
expression.  This evidence clearly indicates that AGR2-client protein is redox 
dependant and that AGR2 interactions are occurring through disulphide bond 
formation.   
Evidence in the literature suggests that AGR2 interacts with BiP/Grp78 (Ryu, et al., 
2013). Going forward it would be helpful to identify the AGR2 client protein 
parameters using mass spectrometry to first determine possible interactions before 
conducting further co-immunoprecipitation experiments.   
AGR2 expression levels are also associated with various cancers, in particular 
hormone dependant breast and prostate cancer and in hormone independent 
colorectal, pancreatic and gastric cancers (Brychtova, et al., 2011).  Due to AGR2's 
association with cancer it was worth investigating if AGR2 had any role in BO and 




AGR2 was not expressed in the normal oesophagus.  AGR2 was found to be 
expressed at low levels in normal gastric tissue in the secretory of the gastric cardia.  
AGR2 has a role in mucus production particularly the MUC2 mucin in the intestines 
(Bergstrom, et al., 2014) (Park, et al., 2009) and in MUC1 and MUC5AC (Patel, et 
al., 2013), so its presence in the normal gastric samples was anticipated.  In BO 
there is an associated change in the morphology of the epithelium of the distal 
oesophagus, where the stratified squamous epithelium is replaced with a metaplastic 
columnar epithelium of mixed morphologies (di Pietro, et al., 2014).  Sections taken 
from human patients with BO showed a great variation in the morphology of the cell 
types between sections (Figure 6.1, C and D).  Examination of AGR2 expression in 
these sections showed expression of AGR2 in areas where the morphology had 
changed to simple columnar epithelium and to areas of gland like tissue.  Expression 
appeared particularly high in the areas resembling gastric secretory cells suggesting 
that these cells may be expressing higher levels of AGR2 than those present in the 
normal gastric epithelium.  Although not tested it would be particularly interesting to 
examine if these gastric-like secretory cells were also expressing any mucins.  If this 
was found to be true it would agree in part that the morphological changes present in 
BO may indeed be a protective adaptation to increased acid secretion from GORD 
(Ostowski, et al., 2007). Further a recent paper by Jiang et al suggest that  AGR2 
positive secretory like cells may centrally involved in the transition to BO at the 
gastro-oesophageal junction (Jiang, et al., 2017).   
Examination of AGR2 expression in OAC taken from patients with oesophageal 
junction tumours showed high expression of AGR2 in areas of secretory-like tissue in 
the same way as those in the BO tissue sections.  There appeared to be no 




AGR2 cells appeared adjacent to the tumour cells.  Experiments with PDAC found 
that discrete subpopulation of AGR2 expressing cells were present neighbouring 
pre-neoplastic lesions (Dumartin, et al., 2016).  In a similar way it could be possible 
that secretion of AGR2 may be a factor in the transformation of BO to OAC.   
It would be useful to stain further samples taken from patients, particularly a series of 
experiments on tissue samples taken from the same patients pre BO and with BO to 
see if the apparent difference in expression of AGR2 between pre-BO and BO holds.  
In addition, it would be useful to examine those patients who have stable BO and 
those where BO develops into OAC to see if the tumours are neighbouring AGR2 
expressing cells.  It would be also useful to try to determine if there is a tissue 
association between AGR2 and mucin production either by co-staining for mucin or 
in situ hybridisation for AGR2 and the various MUC genes using different fluorescent 
tags or stains.   
It would also be useful to examine whether stress effects AGR2 expression in OE19 
cells in culture.  Evidence from Clarke et al suggests that AGR2 dimerisation occurs 
through a sulphenic acid  intermediate and that high concentrations of H2O2 inhibits 
dimer formation (Clarke, et al., 2016).  It would therefore be useful to titrate different 
concentrations H2O2 to examine AGR2 expression and dimer formation to see if this 
is the case in OE19 cells.  In addition it would also be beneficial to expand this 
approach to include other reducing and stress-inducing agents, such as tunicamycin 







The  overall aim of this thesis, was to examine the effects of stress inducing agents 
on chaperone interactions using oesophageal cell lines as a cellular model of BO, 
focusing initially on GPx7 and Prdx4.  This thesis found that GPx7  was not 
expressed or not expressed at sufficient levels to be detected in the oesophageal 
cell lines tested  but that Prxd4 was expressed in OE19 cells and could be detected 
with the Prdx4 [7A1](16943) antibody (Abcam). However, further experiments are 
required to validate GPx7 expression levels with other. Considering AGR2, this 
thesis has shown that AGR2 is not expressed in the normal oesophagus but is 
expressed in BO.  Furthermore AGR2 is associated closely with tumour cells in OAC 
(Figure 6.1 E and F).  In OE19 cells AGR2 was shown to form redox dependant 
dimers as well as interactions with other, as yet unknown, proteins.  This suggests 
that AGR2 plays role in the pathogenesis of OAC and may be an important factor in 
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